syndrome	score	normalized_score
MYOCLONIC EPILEPSY OF LAFORA	1.52803179	100.0
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	1.5	98.16549693642173
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.3055556	85.44034283475214
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	1.0311747820000001	67.48385660222424
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	1.028843151	67.33126612503266
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	1.000843882	65.49889135487163
227210 EYEBROWS, DUPLICATION OF, WITH STRETCHABLE SKIN AND SYNDACTYLY	1.0	65.44366462428115
HYPERTRICHOSIS UNIVERSALIS	1.0	65.44366462428115
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	1.0	65.44366462428115
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.9484125999999999	62.067596119842506
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.6388886	41.811211270676516
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.5833333	38.175468849375186
#121200 SEIZURES, BENIGN FAMILIAL NEONATAL, 1; BFNS1EPILEPSY, BENIGN NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED;;SEIZURES, BENIGN FAMILIAL NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED	0.537771982	35.19376923434296
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.5286430819999999	34.59634056435435
WILLIAMS-BEUREN SYNDROME; WBS	0.52261062	34.20155414436764
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.521450653	34.12564165304441
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.519711782	34.011843562495514
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.5188679	33.95661683190505
EPILEPSY, BENIGN NEONATAL, 2	0.5147059	33.684240299738796
WITTEVEEN-KOLK SYNDROME	0.508382153	33.27039112190199
#614265 COMBINED MALONIC AND METHYLMALONIC ACIDURIA; CMAMMA	0.500843882	32.77705904273104
ROMBO SYNDROME	0.5	32.72183231214058
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	32.72183231214058
VAN DEN ENDE-GUPTA SYNDROME; VDEGS	0.5	32.72183231214058
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.5	32.72183231214058
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.5	32.72183231214058
COMBINED SAPOSIN DEFICIENCY	0.5	32.72183231214058
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.48869108200000005	31.981735275285082
#300672 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2; EIEE2;;INFANTILE SPASM SYNDROME, X-LINKED 2; ISSX2	0.48391435299999996	31.669128624607996
#604403 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 2; GEFSP2;;GEFS+, TYPE 2; GEFS+2FEBRILE SEIZURES, FAMILIAL, 3A, INCLUDED; FEB3A, INCLUDED	0.4663689	30.52088988279491
CENTRALOPATHIC EPILEPSY	0.4484126	29.34576380770193
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.44841259999999994	29.34576380770193
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.44841259999999994	29.34576380770193
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.40576814200000005	26.554954200265694
AICARDI SYNDROME; AIC	0.3964286	25.9437403458733
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.384294782	25.14965883006924
#605751 SEIZURES, BENIGN FAMILIAL INFANTILE, 2; BFIS2;;CONVULSIONS, BENIGN FAMILIAL INFANTILE, 2; BFIC2	0.3824787	25.030807768731044
#602066 CONVULSIONS, FAMILIAL INFANTILE, WITH PAROXYSMAL CHOREOATHETOSIS;ICCA;;INFANTILE CONVULSIONS AND PAROXYSMAL CHOREOATHETOSIS, FAMILIAL;;ICCA SYNDROME;;PAROXYSMAL KINESIGENIC DYSKINESIA WITH INFANTILE CONVULSIONS; PKD/IC	0.3824787	25.030807768731044
CORNELIA DE LANGE SYNDROME 3	0.377450173	24.7017225341889
EPILEPSY, JUVENILE ABSENCE	0.3752738	24.559292709479557
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.3752738	24.559292709479557
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.3741988	24.488940770008455
CHROMOSOME 1P36 DELETION SYNDROME	0.36480157300000005	23.873951797822222
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.36256878200000003	23.727829772442107
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.3613516	23.64817292184739
#607682 EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 9; EIG9EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 6, INCLUDED; EJM6,INCLUDED	0.3596488	23.536735449725164
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc; CDG2C	0.356399082	23.324061994809675
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.35100014	22.970735445235732
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.349801882	22.89231705055037
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.3480389	22.776941047803724
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.333333	21.814533060205505
THUMB AGENESIS, SHORT STATURE, AND IMMUNODEFICIENCY	0.333333	21.814533060205505
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.330749782	21.645477807762102
TUBEROUS SCLEROSIS	0.32591575100000003	21.329121104214725
#607208 DRAVET SYNDROME;;EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 6; EIEE6;;SEVERE MYOCLONIC EPILEPSY OF INFANCY; SMEI	0.317208182	20.759265878885934
#614202 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 15; MRT15	0.292668733	19.153314408465285
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.266468882	17.438700146415147
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.265549782	17.378550874258973
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.2647059	17.323324143668504
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.26348803300000007	17.243622464163526
HYPEREKPLEXIA 1; HKPX1	0.25925926	16.96687606217931
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.256399442	16.779719092100827
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.250915751	16.420846257393638
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.25	16.36091615607029
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	16.36091615607029
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY;;MOLLICA SYNDROME	0.25	16.36091615607029
#604364 EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI; FFEVF;;EPILEPSY, PARTIAL, WITH VARIABLE FOCI; FPEVF	0.25	16.36091615607029
HYPERPARATHYROIDISM 2	0.25	16.36091615607029
#613908 SPINOCEREBELLAR ATAXIA 35; SCA35	0.25	16.36091615607029
#215400 CHORDOMA, SUSCEPTIBILITY TO; CHDM	0.25	16.36091615607029
#215140 GREENBERG DYSPLASIA; GRBGD;;HYDROPS-ECTOPIC CALCIFICATION-MOTH-EATEN SKELETAL DYSPLASIA;;HEM SKELETAL DYSPLASIA;;MOTH-EATEN SKELETAL DYSPLASIA;;CHONDRODYSTROPHY, HYDROPIC AND PRENATALLY LETHAL TYPE	0.25	16.36091615607029
DYSTONIA 6, TORSION	0.25	16.36091615607029
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.25	16.36091615607029
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25	16.36091615607029
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.225923551	14.785265102370678
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.2244281	14.687397308664632
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.2244281	14.687397308664632
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.2244281	14.687397308664632
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.2244281	14.687397308664632
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.2244281	14.687397308664632
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.217216183	14.21542303121848
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.21233818200000001	13.896188769737572
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.210744872	13.791916724455058
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.200915751	13.14866302617958
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.200843882	13.143959655446697
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.200843882	13.143959655446697
NOONAN SYNDROME 6; NS6	0.200843882	13.143959655446697
Oliver-McFarlane syndrome	0.2	13.088732924856231
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.2	13.088732924856231
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.1964286	12.855007421017072
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.194414082	12.723169980645494
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.182143382	11.920130405140327
#613863 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 7; GEFSP7;;GEFS+, TYPE 7; GEFS+7FEBRILE SEIZURES, FAMILIAL, 3B, INCLUDED; FEB3B, INCLUDED	0.1812995	11.864903674549861
RESTRICTIVE DERMOPATHY, LETHAL	0.14801163999999997	9.686424128649834
#615369 EPILEPTIC ENCEPHALOPATHY, CHILDHOOD-ONSET; EEOC	0.14637478199999998	9.579302142660264
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.14370088199999997	9.404312327821398
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.14370088199999997	9.404312327821398
ECTODERMAL DYSPLASIA 8, HAIR/TOOTH/NAIL TYPE	0.14285699999999998	9.349085597230932
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.14285699999999998	9.349085597230932
HYPOTRICHOSIS 12; HYPT12	0.14285699999999998	9.349085597230932
HYPOTRICHOSIS AND RECURRENT SKIN VESICLES	0.14285699999999998	9.349085597230932
HYPOTRICHOSIS 11; HYPT11	0.14285699999999998	9.349085597230932
WAARDENBURG SYNDROME, TYPE 1; WS1	0.13611879999999998	8.9081130962596
#613060 EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 10; EIG10GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 5, SUSCEPTIBILITYTO, INCLUDED; GEFS5, INCLUDED;;GEFS+, TYPE 5, SUSCEPTIBILITY TO, INCLUDED;;GEFS+5, SUSCEPTIBILITY TO, INCLUDED;;GEFSP5, SUSCEPTIBILITY TO, INCLUDED;;EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 7, INCLUDED; EJM7,INCLUDED	0.1344245	8.79723189528668
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2; EDSCLL2	0.13425926	8.786417984144164
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.13423833300000002	8.785048444574574
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.13311626	8.71161587547861
#613722 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 12; EIEE12	0.1324787	8.669891612660756
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.13162252	8.613860055882737
MEIER-GORLIN SYNDROME 7	0.130998522	8.573023340044516
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.12675963299999998	8.295614909948961
TUBEROUS SCLEROSIS 2; TSC2	0.125915751	8.240388179358494
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIx;;CDG-x	0.125915751	8.240388179358494
#615473 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 17; EIEE17	0.125843882	8.235684808625612
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.125843882	8.235684808625612
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.125843882	8.235684808625612
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.125843882	8.235684808625612
#604233 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 1; GEFSP1;;GEFS+, TYPE 1; GEFS+1	0.1257439	8.229141620149145
ECTODERMAL DYSPLASIA 13, HAIR/TOOTH TYPE; ECTD13	0.125	8.180458078035144
HYPOTRICHOSIS 5; HYPT5	0.125	8.180458078035144
#193510 WAARDENBURG SYNDROME, TYPE 2A; WS2A;;WAARDENBURG SYNDROME, TYPE IIA;;WAARDENBURG SYNDROME WITHOUT DYSTOPIA CANTHORUM;;WS2	0.12260529999999999	8.023740134359377
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.118216762	7.736538125296464
#612292 BIRK-BAREL MENTAL RETARDATION DYSMORPHISM SYNDROME;;BIRK-BAREL SYNDROME;;MENTAL RETARDATION WITH HYPOTONIA AND FACIAL DYSMORPHISM	0.1166177	7.631889648055032
RENPENNING SYNDROME 1; RENS1	0.113533311	7.43003592876821
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.11287063299999998	7.386667851982319
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.11195488199999999	7.326737750658969
WAARDENBURG-SHAH SYNDROME	0.11195488199999999	7.326737750658969
WAARDENBURG SYNDROME, TYPE 4B; WS4B	0.11111099999999999	7.271511020068503
TIETZ SYNDROME	0.11111099999999999	7.271511020068503
#613266 WAARDENBURG SYNDROME, TYPE 4C; WS4C;;WAARDENBURG SYNDROME WITH HIRSCHSPRUNG DISEASE, TYPE 4C;;WAARDENBURG SYNDROME, TYPE IVC	0.11111099999999999	7.271511020068503
ERMINE PHENOTYPE	0.11111099999999999	7.271511020068503
WHITE-SUTTON SYNDROME; WHSUS	0.10904060200000001	7.136016587717721
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.1081087	7.075029505767024
MOWAT-WILSON SYNDROME; MOWS	0.105176211	6.883116679136631
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.10416303300000002	6.816810597899931
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.10315597100000003	6.750904770116074
#262600 PITUITARY HORMONE DEFICIENCY, COMBINED, 2; CPHD2;;PANHYPOPITUITARISM;;ATELIOTIC DWARFISM WITH HYPOGONADISM;;PITUITARY DWARFISM III;;HANHART DWARFISM	0.10091575100000001	6.604296563751467
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.1	6.5443664624281155
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.1	6.5443664624281155
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.1	6.5443664624281155
#256450 HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1; HHF1;;PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY; PHHI;;HYPOGLYCEMIA, HYPERINSULINEMIC, OF INFANCY;;HYPERINSULINEMIC HYPOGLYCEMIA DUE TO FOCAL ADENOMATOUS HYPERPLASIA;;NESIDIOBLASTOSIS OF PANCREAS;;HYPERINSULINISM, FAMILIAL, WITH PANCREATIC NESIDIOBLASTOSIS;;HYPERINSULINISM, CONGENITAL	0.1	6.5443664624281155
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.1	6.5443664624281155
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.1	6.5443664624281155
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.1	6.5443664624281155
3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY	0.1	6.5443664624281155
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.09929125300000002	6.497983461456651
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.09884157300000002	6.468554754348403
AYME-GRIPP SYNDROME; AYGRP	0.098447371	6.442756730866182
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.098375502	6.4380533601333
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.09663488200000002	6.324140808614985
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.09523000200000001	6.232200313057624
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.094910382	6.211283208970411
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.09424668200000001	6.167848248759276
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.09266873300000002	6.064581483609056
#600972 ACHONDROGENESIS, TYPE IB; ACG1B;;ACHONDROGENESIS, FRACCARO TYPE	0.09259256000000002	6.059596443343631
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.09087157100000001	5.946968616405553
#300867 KABUKI SYNDROME 2; KABUK2	0.09053797300000001	5.925136740774222
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0902965	5.9093338627464025
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.089731551	5.87236152986058
MECKEL SYNDROME, TYPE 1; MKS1	0.08888886000000001	5.8172127426746805
#614018 EPILEPSY, PROGRESSIVE MYOCLONIC, 6; EPM6	0.0888158	5.81243142853723
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.08865150000000001	5.801679034439461
KNIEST-LIKE DYSPLASIA, LETHAL	0.08848794000000001	5.7909750686535135
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.08424905100000002	5.513566638557959
MEIER-GORLIN SYNDROME 1; MGORS1	0.08333330000000001	5.453636537234609
#610682 OSTEOGENESIS IMPERFECTA, TYPE VII; OI7;;OI, TYPE VII;;OSTEOGENESIS IMPERFECTA, TYPE IIB, FORMERLY; OI2B, FORMERLY	0.08333330000000001	5.453636537234609
#615731 NEMALINE MYOPATHY 9; NEM9	0.08333330000000001	5.453636537234609
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.08333330000000001	5.453636537234609
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.08333330000000001	5.453636537234609
CHROMOSOME 17q12 DELETION SYNDROME	0.08203640000000001	5.368762648583378
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.08138495300000001	5.326129569594885
AU-KLINE SYNDROME; AUKS	0.080469202	5.266199468271534
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.079690553	5.215241824255502
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.07886889999999999	5.1614698408859665
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.078621682	5.145290989004882
#612437 EPILEPSY, PROGRESSIVE MYOCLONIC 1B; EPM1B	0.078125	5.112786298771964
LISSENCEPHALY 2; LIS2	0.07776698200000001	5.08935628885051
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.07776698200000001	5.08935628885051
#615604 L-FERRITIN DEFICIENCY; LFTD	0.07692310000000001	5.034129558260042
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.07692310000000001	5.034129558260042
MYOCLONUS AND ATAXIA	0.07692310000000001	5.034129558260042
CANAVAN DISEASE	0.07692310000000001	5.034129558260042
MCLEOD SYNDROME; MCLDS	0.07692310000000001	5.034129558260042
MENTAL RETARDATION, X-LINKED 98; MRX98	0.076854033	5.0296095606754365
HAMAMY SYNDROME; HMMS	0.07658324000000001	5.011887874400834
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.076358482	4.997178887227209
XQ25 DUPLICATION SYNDROME	0.075087233	4.913983694017256
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.0744235	4.870546574165188
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.0744235	4.870546574165188
POTOCKI-SHAFFER SYNDROME	0.07234435100000002	4.734479444305279
ICHTHYOSIS--CHEEK--EYEBROW SYNDROME	0.07142860000000001	4.674549342981929
DUBOWITZ SYNDROME	0.07142860000000001	4.674549342981929
ULNAR-MAMMARY SYNDROME; UMS	0.07142860000000001	4.674549342981929
ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD11B	0.07142860000000001	4.674549342981929
257960 OCULOTRICHODYSPLASIA; OTD	0.07142860000000001	4.674549342981929
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.0702615	4.59817004199893
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.0702615	4.59817004199893
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.06984130000000001	4.570670614123808
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.06744167100000001	4.4136300986251085
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.06545659000000001	4.2837191234090755
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.064197873	4.201344070204193
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.064163	4.199061853287751
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.06375232	4.172185449099851
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.06326576	4.140343179640261
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.06324389999999999	4.138912581131574
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.06324389999999999	4.138912581131574
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.062892133	4.115891659557684
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.062748582	4.106497156057205
ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED	0.0619047	4.051270425466737
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.061556713	4.028496880945127
#254770 EPILEPSY, MYOCLONIC JUVENILE; EJM;;MYOCLONIC EPILEPSY, JUVENILE; JME;;PETIT MAL, IMPULSIVE;;JANZ SYNDROMEMYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 1, INCLUDED; EJM1,INCLUDED	0.0598896	3.9193948968823484
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.0598141	3.914453900203215
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.058637893	3.837478603766483
GAPO SYNDROME; GAPOS	0.057794011	3.782251873176015
EPILEPSY, IDIOPATHIC GENERALIZED	0.0566467	3.707167636872267
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.056471351	3.695692155724064
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.056399482	3.6909887849911818
METACHROMATIC LEUKODYSTROPHY	0.056352440999999996	3.6879102495635903
COFFIN-LOWRY SYNDROME; CLS	0.056036151	3.6672110728795766
#230600 GM1-GANGLIOSIDOSIS, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, JUVENILE TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 2GANGLIOSIDOSIS, GENERALIZED GM1, LATE-INFANTILE TYPE, INCLUDED	0.055828989999999995	3.653653697872346
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.055555600000000004	3.635762054400714
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.055555600000000004	3.635762054400714
#300491 EPILEPSY, X-LINKED, WITH VARIABLE LEARNING DISABILITIES AND BEHAVIORDISORDERS	0.055555600000000004	3.635762054400714
APNEA, OBSTRUCTIVE SLEEP	0.055555600000000004	3.635762054400714
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.055555600000000004	3.635762054400714
#300643 ROLANDIC EPILEPSY, MENTAL RETARDATION, AND SPEECH DYSPRAXIA, X-LINKED;RESDX	0.055555600000000004	3.635762054400714
JABERI-ELAHI SYNDROME; JABELS	0.055551473000000004	3.63549196839681
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.055085402	3.604990574181706
OROFACIAL CLEFT 15	0.05424152	3.5497638435912386
#156200 MENTAL RETARDATION, AUTOSOMAL DOMINANT 1; MRD1CHROMOSOME 2q23.1 DELETION SYNDROME, INCLUDED	0.05410364	3.5407404711128425
#219000 FRASER SYNDROME;;CRYPTOPHTHALMOS WITH OTHER MALFORMATIONSCRYPTOPHTHALMOS-SYNDACTYLY SYNDROME, INCLUDED	0.05317456	3.4799380711837156
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.052685671999999996	3.4479434488728797
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.050297633	3.291661425447176
EPILEPSY, PYRIDOXINE-DEPENDENT	0.050042682	3.2749764977075513
FEBRILE CONVULSIONS, FAMILIAL, 9	0.048538	3.176504593533358
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.048538	3.176504593533358
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.048534751	3.1762919670669945
#615280 CARDIOFACIOCUTANEOUS SYNDROME 4; CFC4	0.048462882	3.1715885963341113
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.048462882	3.1715885963341113
#615278 CARDIOFACIOCUTANEOUS SYNDROME 2; CFC2	0.048462882	3.1715885963341113
Retinitis pigmentosa with or without skeletal anomalies	0.048462882	3.1715885963341113
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.048462882	3.1715885963341113
#614976 CARPENTER SYNDROME 2; CRPT2	0.048361102	3.1649277401486526
KERATOSIS PILARIS ATROPHICANS; KPA	0.047619	3.116361865743644
TOOTH AGENESIS, SELECTIVE, 8; STHAG8	0.047619	3.116361865743644
TOOTH AGENESIS, SELECTIVE, 4	0.047619	3.116361865743644
SPASTIC PARAPLEGIA WITH NEUROPATHY AND POIKILODERMA	0.047619	3.116361865743644
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA SYNDROME; HLTS	0.047619	3.116361865743644
ABSENT EYEBROWS AND EYELASHES WITH MENTAL RETARDATION	0.047619	3.116361865743644
HYPOTRICHOSIS 10; HYPT10	0.047619	3.116361865743644
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.047619	3.116361865743644
PORPHYRIA, CONGENITAL ERYTHROPOIETIC; CEP	0.047619	3.116361865743644
#602032 ECTODERMAL DYSPLASIA 4, HAIR/NAIL TYPE; ECTD4;;ECTODERMAL DYSPLASIA, 'PURE' HAIR/NAIL TYPE	0.047619	3.116361865743644
KERATOSIS FOLLICULARIS, DWARFISM, AND CEREBRAL ATROPHY	0.047619	3.116361865743644
PARC SYNDROME	0.047619	3.116361865743644
MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; MACID	0.047619	3.116361865743644
ABLEPHARON-MACROSTOMIA SYNDROME	0.047619	3.116361865743644
BARTSOCAS-PAPAS SYNDROME; BPS	0.047619	3.116361865743644
#613456 FRONTONASAL DYSPLASIA 3; FND3	0.047619	3.116361865743644
HYPOTRICHOSIS 1; HYPT1	0.047619	3.116361865743644
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.047619	3.116361865743644
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.047619	3.116361865743644
601375 ECTODERMAL DYSPLASIA, HIDROTIC, CHRISTIANSON-FOURIE TYPE	0.047619	3.116361865743644
CHROMOSOME 18Q DELETION SYNDROME	0.046579651	3.0483430583600617
Adrenoleukodystrophy	0.046451451	3.0399531805552287
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.046379581999999996	3.0352498098223464
#257300 MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1; MVA1;;MVA SYNDROME	0.04250898	2.781943430640275
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.041865582	2.7398371077083414
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.041865582	2.7398371077083414
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.041311703	2.7035892361899094
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.041206352999999994	2.6966947461217408
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.04115099	2.6930715885171472
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.04115099	2.6930715885171472
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.04115099	2.6930715885171472
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.0410217	2.684610377117874
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.040362471	2.6414680155312733
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.039975711	2.6161570238011866
#102500 HAJDU-CHENEY SYNDROME; HJCYS;;ACROOSTEOLYSIS WITH OSTEOPOROSIS AND CHANGES IN SKULL AND MANDIBLE;;CHENEY SYNDROME;;ARTHRODENTOOSTEODYSPLASIA;;SERPENTINE FIBULA-POLYCYSTIC KIDNEY SYNDROME; SFPKS	0.039822619999999996	2.6061381877401906
#219100 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IA; ARCL1A;;ARCL1;;CUTIS LAXA, AUTOSOMAL RECESSIVE	0.039562259999999995	2.589099275218613
MARSHALL-SMITH SYNDROME; MRSHSS	0.0394217	2.5799005137190236
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.039343602	2.5747894943991967
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.038962533	2.549850942564487
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.038716402	2.5337432279468475
PEROXISOME BIOGENESIS DISORDER 6B	0.038266721999999996	2.504314520838601
ALAZAMI-YUAN SYNDROME	0.038046782	2.489920841241137
#614701 CORNELIA DE LANGE SYNDROME 4; CDLS4	0.038046782	2.489920841241137
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.038046782	2.489920841241137
GOLDBERG-SHPRINTZEN SYNDROME	0.038046782	2.489920841241137
LISSENCEPHALY 5; LIS5	0.037721311	2.4686208262722076
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.037649442	2.463917455539325
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.037351782	2.4444374943272615
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.037351782	2.4444374943272615
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.037351782	2.4444374943272615
OCULODENTODIGITAL DYSPLASIA; ODDD	0.037320391	2.4423831522510406
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.0369281	2.4167101916119167
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.0369281	2.4167101916119167
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5	0.03680556	2.4086907249488574
PALLISTER-KILLIAN SYNDROME	0.036237871	2.3715390764219633
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.036009353	2.3565840210693523
COFFIN-SIRIS SYNDROME 1; CSS1	0.035859873	2.346801502081315
EDINBURGH MALFORMATION SYNDROME	0.03585856	2.346715574549663
ZIMMERMANN-LABAND SYNDROME 1	0.035182810999999994	2.3024920836234695
DESANTO-SHINAWI SYNDROME	0.034964153	2.2881823028040533
WIEDEMANN-STEINER SYNDROME; WDSTS	0.034964153	2.2881823028040533
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.03456644	2.2621545066153366
#613721 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 11; EIEE11	0.034417682	2.252419237953158
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.034417682	2.252419237953158
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.03425958	2.24207246368873
HAREL-YOON SYNDROME; HAYOS	0.033782202	2.2108310979577195
#616351 MENTAL RETARDATION, AUTOSOMAL DOMINANT 34; MRD34	0.033666602	2.2032658103271525
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.033645753	2.201901375363401
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.0335738	2.1971925073626903
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.033485651	2.1914237137697246
KABUKI SYNDROME 1	0.033395073	2.185495957515386
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.033038941	2.162189374345412
LISSENCEPHALY 1; LIS1	0.033009633	2.1602713514226033
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.033009633	2.1602713514226033
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.033009633	2.1602713514226033
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.033009633	2.1602713514226033
3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY; HMGCLD	0.033009633	2.1602713514226033
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.032730001999999994	2.141971274040051
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.032546070999999996	2.1299341553620423
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.032474202	2.12523078462916
MEGALENCEPHALY WITH DYSMYELINATION	0.032165751	2.1050446208321363
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.032165751	2.1050446208321363
#222748 DIHYDROPYRIMIDINASE DEFICIENCY;;DIHYDROPYRIMIDINURIA;;DPYS DEFICIENCY;;DPH DEFICIENCY	0.032165751	2.1050446208321363
GABRIELE-DE VRIES SYNDROME; GADEVS	0.032093882	2.1003412500992535
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.032093882	2.1003412500992535
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.032093882	2.1003412500992535
CHROMOSOME 3pter-p25 DELETION SYNDROME	0.032071553	2.098879958511858
FONTAINE PROGEROID SYNDROME; FPS	0.03146376	2.0591037572588724
#221820 LEUKOENCEPHALOPATHY, DIFFUSE HEREDITARY, WITH SPHEROIDS; HDLS;;LEUKOENCEPHALOPATHY WITH NEUROAXONAL SPHEROIDS, AUTOSOMAL DOMINANT;;GLIOSIS, FAMILIAL PROGRESSIVE SUBCORTICAL; GPSC;;DEMENTIA, FAMILIAL, NEUMANN TYPE;;SUBCORTICAL GLIOSIS OF NEUMANN	0.03125	2.045114519508786
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.03125	2.045114519508786
MYELOCEREBELLAR DISORDER	0.03125	2.045114519508786
#606612 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH OR WITHOUTMENTAL RETARDATION), TYPE B, 5; MDDGB5;;MUSCULAR DYSTROPHY, CONGENITAL, 1C; MDC1C;;MUSCULAR DYSTROPHY, CONGENITAL, FKRP-RELATED	0.03125	2.045114519508786
#302800 CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1; CMTX1;;CMTX;;CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY, X-LINKED;;HEREDITARY MOTOR AND SENSORY NEUROPATHY, X-LINKED;;HMSN, X-LINKED;;CHARCOT-MARIE-TOOTH NEUROPATHY, X-LINKED, 1;;CMT2, FORMERLY	0.03125	2.045114519508786
#128200 EPISODIC KINESIGENIC DYSKINESIA 1; EKD1;;PAROXYSMAL KINESIGENIC CHOREOATHETOSIS; PKC;;PAROXYSMAL KINESIGENIC DYSKINESIA; PKD;;DYSTONIA, FAMILIAL PAROXYSMAL;;DYSTONIA 10; DYT10	0.031218750999999996	2.0430694704329415
MENKES DISEASE	0.031218750999999996	2.0430694704329415
15q13.3 microdeletion syndrome	0.031218750999999996	2.0430694704329415
AMAUROSIS CONGENITA, CONE-ROD TYPE, WITH CONGENITAL HYPERTRICHOSIS	0.031180639999999996	2.0405753469304457
#616341 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 30; EIEE30	0.031174782	2.040191977943077
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.031155802	2.038949857188508
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.031146881999999997	2.038366099700059
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.0303309	1.9849652473526092
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.0303309	1.9849652473526092
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.0303309	1.9849652473526092
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.0303309	1.9849652473526092
#133540 COCKAYNE SYNDROME, TYPE B; CSB;;CKN2	0.030327550999999998	1.9847460765197822
#208900 ATAXIA-TELANGIECTASIA; AT;;AT1;;LOUIS-BAR SYNDROMEAT, COMPLEMENTATION GROUP A, INCLUDED; ATA, INCLUDED;;AT, COMPLEMENTATION GROUP C, INCLUDED; ATC, INCLUDED;;AT, COMPLEMENTATION GROUP D, INCLUDED; ATD, INCLUDED;;AT, COMPLEMENTATION GROUP E, INCLUDED; ATE, INCLUDED;;ATAXIA-TELANGIECTASIA VARIANT, INCLUDED	0.030327550999999998	1.9847460765197822
Growth hormone deficiency, isolated, type IA	0.030302999999999997	1.9831393691095913
NASAL ALAR COLLAPSE, BILATERAL	0.030302999999999997	1.9831393691095913
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.030302999999999997	1.9831393691095913
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.030302999999999997	1.9831393691095913
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.030302999999999997	1.9831393691095913
SPEECH-LANGUAGE DISORDER 1	0.030302999999999997	1.9831393691095913
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.030302999999999997	1.9831393691095913
OROFACIAL CLEFT 3	0.030302999999999997	1.9831393691095913
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.030302999999999997	1.9831393691095913
DWARFISM, LEVI TYPE	0.030302999999999997	1.9831393691095913
#604367 LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 3; FPLD3;;LIPODYSTROPHY, FAMILIAL PARTIAL, ASSOCIATED WITH PPARG MUTATIONS	0.030302999999999997	1.9831393691095913
15q24 recurrent microdeletion syndrome	0.030302999999999997	1.9831393691095913
DIMPLES, FACIAL	0.030302999999999997	1.9831393691095913
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.030302999999999997	1.9831393691095913
NASAL GROOVE, FAMILIAL TRANSVERSE	0.030302999999999997	1.9831393691095913
#230650 GM1-GANGLIOSIDOSIS, TYPE III;;GANGLIOSIDOSIS, GENERALIZED GM1, ADULT TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, CHRONIC TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE III;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 3	0.030302999999999997	1.9831393691095913
NASAL BONES, ABSENCE OF	0.030302999999999997	1.9831393691095913
CYANIDE, INABILITY TO SMELL	0.030302999999999997	1.9831393691095913
OSTEOPENIA AND SPARSE HAIR	0.030302999999999997	1.9831393691095913
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.030302999999999997	1.9831393691095913
22q11.2 distal deletion syndrome	0.030302999999999997	1.9831393691095913
CLEFT CHIN	0.030302999999999997	1.9831393691095913
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.030302999999999997	1.9831393691095913
WAARDENBURG SYNDROME, TYPE IIB	0.030302999999999997	1.9831393691095913
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.030302999999999997	1.9831393691095913
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.030255682	1.9800427057868997
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.0299107	1.957465819477486
TENORIO SYNDROME; TNORS	0.029885800999999997	1.955836337672006
EVEN-PLUS SYNDROME	0.029687922000000002	1.942886410759818
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.029571011	1.9352353264849287
138920 GRANDDAD SYNDROME;;GROWTH RETARDATION, AGED FACIES, NORMAL DEVELOPMENT, DECREASED SUBCUTANEOUSFAT, AUTOSOMAL DOMINANT INHERITANCE	0.0294118	1.9248159751964322
HAIRY NOSE TIP	0.0294118	1.9248159751964322
WERNER SYNDROME; WRN	0.0294118	1.9248159751964322
MIDPHALANGEAL HAIR	0.0294118	1.9248159751964322
RINGED HAIR	0.0294118	1.9248159751964322
CATATRICHY	0.0294118	1.9248159751964322
ALBINISM, OCULOCUTANEOUS, TYPE VI; OCA6	0.0294118	1.9248159751964322
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 6	0.0294118	1.9248159751964322
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.0294118	1.9248159751964322
VAN BOGAERT-HOZAY SYNDROME	0.0294118	1.9248159751964322
HERMANSKY-PUDLAK SYNDROME 1; HPS1	0.0294118	1.9248159751964322
#250460 METAPHYSEAL DYSPLASIA WITHOUT HYPOTRICHOSIS;;CARTILAGE-HAIR HYPOPLASIA-LIKE SKELETAL DYSPLASIA WITHOUT HYPOTRICHOSISOR IMMUNODEFICIENCY;;CARTILAGE-HAIR HYPOPLASIA VARIANT, SKELETAL MANIFESTATIONS ONLY; CHHV	0.0294118	1.9248159751964322
SCALP-EAR-NIPPLE SYNDROME; SENS	0.0294118	1.9248159751964322
TRICHODISCOMAS, FAMILIAL MULTIPLE	0.0294118	1.9248159751964322
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.0294118	1.9248159751964322
#206920 MICROPHTHALMIA WITH LIMB ANOMALIES;;WAARDENBURG ANOPHTHALMIA SYNDROME;;ANOPHTHALMIA-SYNDACTYLY;;OPHTHALMOACROMELIC SYNDROME; OAS	0.0294118	1.9248159751964322
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.0294118	1.9248159751964322
TRICHODENTOOSSEOUS SYNDROME	0.0294118	1.9248159751964322
ICHTHYOSIS, SPLIT HAIRS, AND AMINO ACIDURIA	0.0294118	1.9248159751964322
ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS	0.0294118	1.9248159751964322
611426 TENTED EYEBROWS	0.0294118	1.9248159751964322
HAIR WHORL	0.0294118	1.9248159751964322
RED SKIN PIGMENT ANOMALY OF NEW GUINEA	0.0294118	1.9248159751964322
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2	0.0294118	1.9248159751964322
MANITOBA OCULOTRICHOANAL SYNDROME	0.0294118	1.9248159751964322
%152800 LYMPHANGIECTASIA, INTESTINAL	0.0294118	1.9248159751964322
AMELOONYCHOHYPOHIDROTIC SYNDROME	0.0294118	1.9248159751964322
HALLERMANN-STREIFF SYNDROME; HSS	0.0289916	1.8973165473213094
PETERS-PLUS SYNDROME; PTRPLS	0.028351613	1.8554334527294096
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.028328319999999997	1.8539090734493158
#300868 MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2; MCAHS2	0.028246042	1.8485244996113597
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.027324682000000003	1.788227324773132
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.027159682	1.7774291201101255
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.027159682	1.7774291201101255
MENTAL RETARDATION, X-LINKED 41	0.027159682	1.7774291201101255
ERYTHERMALGIA, PRIMARY	0.027064619999999998	1.7712079144636117
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.026767433	1.7517589081049156
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.026552482000000002	1.737691726950262
CHAR SYNDROME	0.026552482000000002	1.737691726950262
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.0264808	1.733000594182664
SIMOSA CRANIOFACIAL SYNDROME	0.0264808	1.733000594182664
#612269 EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 5; ECA5	0.0263158	1.7222023895196579
CHROMOSOME Xp11.23-p11.22 DUPLICATION SYNDROME	0.0263158	1.7222023895196579
MYOCLONIC-ATONIC EPILEPSY	0.0263158	1.7222023895196579
#252940 MUCOPOLYSACCHARIDOSIS, TYPE IIID; MPS3D;;MPS IIID;;SANFILIPPO SYNDROME D;;N-ACETYLGLUCOSAMINE-6-SULFATASE DEFICIENCY	0.025923550999999996	1.6965321775144477
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.025884622	1.6939845210942894
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.025884622	1.6939845210942894
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.025884622	1.6939845210942894
FUMARASE DEFICIENCY; FMRD	0.025884622	1.6939845210942894
HOLOPROSENCEPHALY 11	0.025851682	1.6918288067815659
ELSAHY-WATERS SYNDROME; ESWS	0.025851682	1.6918288067815659
ROIFMAN-CHITAYAT SYNDROME	0.025728142000000002	1.6837438964538824
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.025708599999999998	1.6824649963597942
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.025449033	1.6654779806642637
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.025449033	1.6654779806642637
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.025102441	1.6427957300548048
#125310 CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTSAND LEUKOENCEPHALOPATHY; CADASIL;;DEMENTIA, HEREDITARY MULTI-INFARCT TYPE;;CASIL	0.025102441	1.6427957300548048
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.02504074	1.6387577905038218
ALPHA-METHYLACYL-CoA RACEMASE DEFICIENCY; AMACRD	0.02504074	1.6387577905038218
#610189 SENIOR-LOKEN SYNDROME 6; SLSN6	0.02504074	1.6387577905038218
HYDROCEPHALUS, NORMAL-PRESSURE	0.025030572	1.6380923593219223
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.025030572	1.6380923593219223
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.025007799999999997	1.6366020761910978
MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA	0.025007799999999997	1.6366020761910978
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.025007799999999997	1.6366020761910978
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.025007799999999997	1.6366020761910978
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.025007799999999997	1.6366020761910978
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.024888011	1.6287626450494201
CHROMOSOME 9P DELETION SYNDROME	0.024816142	1.6240592743165374
PELGER-HUET ANOMALY; PHA	0.024809042	1.6235946242977053
#305450 OPITZ-KAVEGGIA SYNDROME; OKS;;FG SYNDROME 1; FGS1;;FG SYNDROME; FGS;;MENTAL RETARDATION, LARGE HEAD, IMPERFORATE ANUS, CONGENITAL HYPOTONIA,AND PARTIAL AGENESIS OF CORPUS CALLOSUM;;KELLER SYNDROME	0.024771173	1.6211163381620481
#194190 WOLF-HIRSCHHORN SYNDROME; WHS;;CHROMOSOME 4p16.3 DELETION SYNDROME;;PITT-ROGERS-DANKS SYNDROME; PRDS;;PITT SYNDROME	0.024664933	1.6141636032323647
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.02460689	1.6103650566065775
CORNELIA DE LANGE SYNDROME 1	0.024605151	1.6102512500737958
Temtamy preaxial brachydactyly syndrome	0.024533282	1.6055478793409135
HOLOPROSENCEPHALY 5; HPE5	0.024516261999999997	1.604434028169008
#252500 MUCOLIPIDOSIS II ALPHA/BETA;;MUCOLIPIDOSIS II; ML II;;ML II ALPHA/BETA;;I-CELL DISEASE; ICD	0.024388842	1.5960951964225822
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.024366462000000002	1.594630567208291
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.02418669	1.5828656287314546
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.02418669	1.5828656287314546
FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	0.02418669	1.5828656287314546
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.02418669	1.5828656287314546
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	0.02418669	1.5828656287314546
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.0240785	1.5757852786557538
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.024022540000000002	1.572123051183379
#615516 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 38; MRT38	0.023981833	1.5694590359275185
HYPERTELORISM, TEEBI TYPE; TBHS	0.023972260000000002	1.5688325437260704
MACS SYNDROME	0.02354496	1.5408684658321146
SCHAAF-YANG SYNDROME; SHFYNG	0.023469853	1.5359531885131787
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.023454502000000002	1.5349485628175314
#176000 PORPHYRIA, ACUTE INTERMITTENT;;AIP;;PORPHYRIA, SWEDISH TYPE;;PORPHOBILINOGEN DEAMINASE DEFICIENCY;;PBGD DEFICIENCY;;UROPORPHYRINOGEN SYNTHASE DEFICIENCY;;UPS DEFICIENCYPORPHYRIA, ACUTE INTERMITTENT, NONERYTHROID VARIANT, INCLUDED;;PORPHYRIA, CHESTER TYPE, INCLUDED; PORC, INCLUDED	0.023398171	1.531262055745581
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.023398171	1.531262055745581
#615033 SPASTIC PARAPLEGIA 54, AUTOSOMAL RECESSIVE; SPG54	0.023326302	1.5265586850126986
MCDONOUGH SYNDROME	0.02327146	1.5229696235573738
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.023066082	1.5095289346041683
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.023066082	1.5095289346041683
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.022641722	1.481757261084208
COFFIN-SIRIS SYNDROME 7; CSS7	0.022554102	1.4760230871898288
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.022554102	1.4760230871898288
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.022554102	1.4760230871898288
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.02248242	1.4713319544222307
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.022298242000000003	1.4592786711590602
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.0222222	1.4543022040137006
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.0222222	1.4543022040137006
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.0222222	1.4543022040137006
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.0222222	1.4543022040137006
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.0222222	1.4543022040137006
MENTAL RETARDATION, X-LINKED 77	0.0222222	1.4543022040137006
EPILEPSY, HOT WATER, 1	0.0222222	1.4543022040137006
Glycosylphosphatidylinositol biosynthesis defect 18	0.022151453	1.4496722610725266
#614706 CEROID LIPOFUSCINOSIS, NEURONAL, 11; CLN11	0.02179784	1.4265305304937406
EMANUEL SYNDROME	0.021733513	1.4223207358794545
SMITH-MAGENIS SYNDROME; SMS	0.021450652999999997	1.4038093409038301
COFFIN-SIRIS SYNDROME 3; CSS3	0.021445973	1.4035030645533888
COFFIN-SIRIS SYNDROME 4; CSS4	0.021445973	1.4035030645533888
COFFIN-SIRIS SYNDROME 2; CSS2	0.021445973	1.4035030645533888
YUNIS-VARON SYNDROME	0.020908219999999998	1.3683105375706874
OROFACIODIGITAL SYNDROME XVIII; OFD18	0.020908219999999998	1.3683105375706874
FRONTONASAL DYSPLASIA 2; FND2	0.020908219999999998	1.3683105375706874
#610168 LOEYS-DIETZ SYNDROME 2; LDS2;;AORTIC ANEURYSM, FAMILIAL THORACIC 3; AAT3;;MARFAN SYNDROME, TYPE II, FORMERLY	0.020813342	1.362101373558465
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.020666553	1.3524949634719314
HYPERPROLINEMIA, TYPE I	0.020627533	1.349941351678292
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.020627533	1.349941351678292
COHEN SYNDROME	0.020602091	1.3482763339629211
SPASTIC PARAPLEGIA 16, X-LINKED	0.02045854	1.338881830462441
#604360 SPASTIC PARAPLEGIA 11, AUTOSOMAL RECESSIVE; SPG11;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, WITH MENTAL IMPAIRMENT ANDTHIN CORPUS CALLOSUM;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, COMPLICATED, WITH THIN CORPUSCALLOSUM;;HSP-TCC	0.02045854	1.338881830462441
#270700 SPASTIC PARAPLEGIA 15, AUTOSOMAL RECESSIVE; SPG15;;SPASTIC PARAPLEGIA AND RETINAL DEGENERATION;;KJELLIN SYNDROME	0.02045854	1.338881830462441
COFFIN-SIRIS SYNDROME 5	0.020427773	1.3368683252329454
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.020356091	1.3321771924653478
OGDEN SYNDROME; OGDNS	0.020284222	1.3274738217324655
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.020136019999999998	1.3177749397478173
COHEN-GIBSON SYNDROME; COGIS	0.020004132	1.3091437057078505
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.019876453	1.3007879240522868
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.019857343	1.299537295621317
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.019857343	1.299537295621317
CEREBROOCULONASAL SYNDROME	0.01984126	1.2984847651631646
NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO; NTD	0.01984126	1.2984847651631646
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.019733371	1.2914241136305153
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.019711782	1.290011250354942
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.019711782	1.290011250354942
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.019711782	1.290011250354942
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.019711782	1.290011250354942
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.019711782	1.290011250354942
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.019711782	1.290011250354942
Congenital disorder of glycosylation, type IIh	0.019711782	1.290011250354942
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.019711782	1.290011250354942
BETA-UREIDOPROPIONASE DEFICIENCY	0.019711782	1.290011250354942
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.019711782	1.290011250354942
RING CHROMOSOME 14 SYNDROME	0.019711782	1.290011250354942
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.019711782	1.290011250354942
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.019711782	1.290011250354942
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.019711782	1.290011250354942
PEHO-LIKE SYNDROME; PEHOL	0.019711782	1.290011250354942
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.019711782	1.290011250354942
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.019711782	1.290011250354942
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.019711782	1.290011250354942
Myhre syndrome	0.019583891	1.2816415946424777
#300004 CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA;;ACC WITH ABNORMAL GENITALIA;;PROUD SYNDROME	0.019426772999999998	1.27135921694404
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.019215613	1.2575401327219768
#156550 KNIEST DYSPLASIA	0.01916025	1.2539169751173829
BRITTLE CORNEA SYNDROME 2; BCS2	0.01916025	1.2539169751173829
SHASHI-PENA SYNDROME; SHAPNS	0.019109373	1.2505873977922932
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.019109373	1.2505873977922932
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.01906906	1.2479491673402945
#300143 MENTAL RETARDATION, X-LINKED 21; MRX21;;MENTAL RETARDATION, X-LINKED 34; MRX34	0.019032570999999998	1.2455611934618191
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.019032570999999998	1.2455611934618191
KLEEFSTRA SYNDROME	0.019032570999999998	1.2455611934618191
#300860 MENTAL RETARDATION, X-LINKED, SYNDROMIC, NASCIMENTO TYPE; MRXSN;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 30; MRXS30	0.019032570999999998	1.2455611934618191
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.018960702	1.2408578227289369
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0188679	1.2347845197644742
DIASTEMATOMYELIA	0.0188679	1.2347845197644742
MOTION SICKNESS	0.0188679	1.2347845197644742
PALMOMENTAL REFLEX	0.0188679	1.2347845197644742
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0188679	1.2347845197644742
#220100 CYSTINURIA;;CSNU;;CYSTINURIA, TYPE I, FORMERLY; CSNU1, FORMERLY;;CYSTINURIA, TYPE II, FORMERLY;;CYSTINURIA, TYPE III, FORMERLY; CSNU3, FORMERLY;;CYSTINURIA, TYPE NON-I, FORMERLYCYSTINURIA, TYPE A, INCLUDED;;CYSTINURIA, TYPE B, INCLUDED;;CYSTINURIA, TYPE A/B, INCLUDED	0.0188679	1.2347845197644742
#259420 OSTEOGENESIS IMPERFECTA, TYPE III;;OI, TYPE III;;OI3;;OSTEOGENESIS IMPERFECTA, PROGRESSIVELY DEFORMING, WITH NORMAL SCLERAE	0.0188679	1.2347845197644742
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0188679	1.2347845197644742
MYOPATHY, CONGENITAL	0.0188679	1.2347845197644742
269800 SENILE PLAQUE FORMATION	0.0188679	1.2347845197644742
RHEUMATOID ARTHRITIS	0.0188679	1.2347845197644742
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0188679	1.2347845197644742
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0188679	1.2347845197644742
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0188679	1.2347845197644742
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0188679	1.2347845197644742
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.0188679	1.2347845197644742
MERALGIA PARAESTHETICA, FAMILIAL	0.0188679	1.2347845197644742
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0188679	1.2347845197644742
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0188679	1.2347845197644742
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0188679	1.2347845197644742
141405 HEMIFACIAL SPASM, FAMILIAL	0.0188679	1.2347845197644742
JUMPING FRENCHMAN OF MAINE	0.0188679	1.2347845197644742
CARDIAC ARRHYTHMIA	0.0188679	1.2347845197644742
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0188679	1.2347845197644742
SPASTIC PSEUDOSCLEROSIS	0.0188679	1.2347845197644742
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0188679	1.2347845197644742
ANDROSTENONE, ABILITY TO SMELL	0.0188679	1.2347845197644742
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0188679	1.2347845197644742
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0188679	1.2347845197644742
GRANULOMAS, CONGENITAL CEREBRAL	0.0188679	1.2347845197644742
COGNITIVE FUNCTION 1, SOCIAL	0.0188679	1.2347845197644742
CERVICAL RIB	0.0188679	1.2347845197644742
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0188679	1.2347845197644742
TRANSSEXUALITY	0.0188679	1.2347845197644742
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0188679	1.2347845197644742
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0188679	1.2347845197644742
NOVELTY SEEKING PERSONALITY TRAIT	0.0188679	1.2347845197644742
SPATIAL VISUALIZATION, APTITUDE FOR	0.0188679	1.2347845197644742
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.0188679	1.2347845197644742
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0188679	1.2347845197644742
THUMBS, CONGENITAL CLASPED	0.0188679	1.2347845197644742
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0188679	1.2347845197644742
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0188679	1.2347845197644742
#601277 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4A; ARCI4A;;ICHTHYOSIS CONGENITA IIB; ICR2B;;ICHTHYOSIS, LAMELLAR, 2, FORMERLY; LI2, FORMERLY	0.0188679	1.2347845197644742
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0188679	1.2347845197644742
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.0188679	1.2347845197644742
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0188679	1.2347845197644742
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0188679	1.2347845197644742
PERONEAL NERVE, ACCESSORY DEEP	0.0188679	1.2347845197644742
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.0188679	1.2347845197644742
ALCOHOL DEPENDENCE	0.0188679	1.2347845197644742
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0188679	1.2347845197644742
#614652 COENZYME Q10 DEFICIENCY, PRIMARY, 3; COQ10D3	0.0188679	1.2347845197644742
#610127 CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10;;CEROID LIPOFUSCINOSIS, NEURONAL, CATHEPSIN D-DEFICIENT;;NEURONAL CEROID LIPOFUSCINOSIS DUE TO CATHEPSIN D DEFICIENCYNEURONAL CEROID LIPOFUSCINOSIS, CONGENITAL, INCLUDED	0.0188679	1.2347845197644742
ENDOCARDIAL FIBROELASTOSIS	0.0188679	1.2347845197644742
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0188679	1.2347845197644742
JOUBERT SYNDROME 14	0.018594542	1.21689497049011
RAINE SYNDROME	0.018594542	1.21689497049011
CHROMOSOME 17P13.1 DELETION SYNDROME	0.018594542	1.21689497049011
AL KAISSI SYNDROME; ALKAS	0.018408573	1.2047244776235972
JOUBERT SYNDROME 3; JBTS3	0.01836794	1.2020653051989187
CHROMOSOME 15Q14 DELETION SYNDROME	0.018193622000000003	1.1906572964689435
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.01811682	1.1856310921384692
PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22	0.01809771	1.184380463707499
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.017833463	1.1670871716615268
IMMUNODEFICIENCY 49; IMD49	0.017641413	1.1545187158704335
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.01745598	1.1423833008081592
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.01745598	1.1423833008081592
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.017384633	1.1377140916682107
3MC SYNDROME 1	0.017349740000000002	1.1354305658784758
PSEUDOTRISOMY 13 SYNDROME	0.01733272	1.1343167147065703
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.017191733	1.125090008762187
#214500 CHEDIAK-HIGASHI SYNDROME; CHS	0.016989581	1.111860441071059
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.016989581	1.111860441071059
#180700 ROBINOW SYNDROME, AUTOSOMAL DOMINANT; DRS;;ROBINOW DWARFISM;;FETAL FACE SYNDROME;;ACRAL DYSOSTOSIS WITH FACIAL AND GENITAL ABNORMALITIES	0.016725662000000002	1.0945886145470838
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.016725662000000002	1.0945886145470838
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.016578873	1.08498220446055
#612938 GROWTH RETARDATION, DEVELOPMENTAL DELAY, COARSE FACIES, AND EARLYDEATH; GDFD	0.016574453	1.0846929434629105
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.016540751	1.082487361077743
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.016540751	1.082487361077743
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.016468882	1.0777839903448607
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.016468882	1.0777839903448607
#614457 ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR	0.016468882	1.0777839903448607
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.016468882	1.0777839903448607
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.016468882	1.0777839903448607
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.016468882	1.0777839903448607
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.016468882	1.0777839903448607
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.016468882	1.0777839903448607
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.016468882	1.0777839903448607
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.016468882	1.0777839903448607
#610951 CEROID LIPOFUSCINOSIS, NEURONAL, 7; CLN7	0.016468882	1.0777839903448607
#300848 MENTAL RETARDATION, X-LINKED 89; MRX89	0.016468882	1.0777839903448607
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.016173533	1.0584552694417437
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.01607383	1.051930339747709
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.016045333000000002	1.050065391636911
HUNTER-MACDONALD SYNDROME	0.015881779999999998	1.0393618839566157
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.015881779999999998	1.0393618839566157
PITT-HOPKINS SYNDROME	0.015734990999999997	1.029755473870082
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.015734990999999997	1.029755473870082
MUCOPOLYSACCHARIDOSIS, TYPE II	0.015730571	1.0294662128724428
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.015730571	1.0294662128724428
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.015658702	1.0247628421395605
HURLER SYNDROME	0.015658702	1.0247628421395605
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.015625	1.022557259754393
#231000 GAUCHER DISEASE, TYPE III;;GD III;;GAUCHER DISEASE, SUBACUTE NEURONOPATHIC TYPE;;GAUCHER DISEASE, CHRONIC NEURONOPATHIC TYPE;;GAUCHER DISEASE, JUVENILE AND ADULT, CEREBRALGAUCHER DISEASE, TYPE IIIA, INCLUDED;;GAUCHER DISEASE, TYPE IIIB, INCLUDED;;GAUCHER DISEASE, NORRBOTTNIAN TYPE, INCLUDED	0.015625	1.022557259754393
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.015625	1.022557259754393
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.015625	1.022557259754393
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.015625	1.022557259754393
PAINE SYNDROME	0.015625	1.022557259754393
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.015625	1.022557259754393
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.015625	1.022557259754393
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.015625	1.022557259754393
MICROHYDRANENCEPHALY; MHAC	0.015625	1.022557259754393
#609304 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 3; EIEE3	0.015625	1.022557259754393
CARNOSINEMIA	0.015625	1.022557259754393
HYDROXYLYSINURIA	0.015625	1.022557259754393
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.015621650999999999	1.022338088921566
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.015621650999999999	1.022338088921566
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.015549782	1.0176347181886838
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.015549782	1.0176347181886838
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.015549782	1.0176347181886838
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.015549782	1.0176347181886838
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.015549782	1.0176347181886838
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.015329651	1.003228538851276
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.015329651	1.003228538851276
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.015285311	1.0003267667618354
LOWE OCULOCEREBRORENAL SYNDROME	0.015285311	1.0003267667618354
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.015273133	0.999529793814041
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.015273133	0.999529793814041
KLEEFSTRA SYNDROME 2; KLEFS2	0.015273133	0.999529793814041
PHELAN-MCDERMID SYNDROME; PHMDS	0.015273133	0.999529793814041
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm; CDG2M	0.015273133	0.999529793814041
KBG SYNDROME	0.015273133	0.999529793814041
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.015273133	0.999529793814041
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.015257782000000001	0.9985251681183938
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.015213442	0.995623396028953
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.015201451	0.9948386610464433
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.015201451	0.9948386610464433
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.015201451	0.9948386610464433
#610768 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Im; CDG1M;;CDG Im; CDGIm;;DOLICHOL KINASE DEFICIENCY;;DK1 DEFICIENCY	0.015201451	0.9948386610464433
#603516 SPINOCEREBELLAR ATAXIA 10; SCA10	0.015201451	0.9948386610464433
#607136 SPINOCEREBELLAR ATAXIA 17; SCA17;;HUNTINGTON DISEASE-LIKE 4; HDL4	0.015201451	0.9948386610464433
OHDO SYNDROME	0.015201451	0.9948386610464433
ROSSELLI-GULIENETTI SYNDROME	0.015129582	0.9901352903135608
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.015129582	0.9901352903135608
CEREBELLOFACIODENTAL SYNDROME	0.015129582	0.9901352903135608
NETHERTON SYNDROME; NETH	0.015129582	0.9901352903135608
NOONAN SYNDROME 9; NS9	0.015129582	0.9901352903135608
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.015129582	0.9901352903135608
CDAGS SYNDROME	0.015129582	0.9901352903135608
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.015129582	0.9901352903135608
CURRARINO SYNDROME	0.015129582	0.9901352903135608
611961 STEVENSON-CAREY SYNDROME	0.015110993	0.9889187580318601
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.01481482	0.9695361115490927
FOCAL DERMAL HYPOPLASIA; FDH	0.01481482	0.9695361115490927
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.01481482	0.9695361115490927
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.01481482	0.9695361115490927
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.01481482	0.9695361115490927
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.0147059	0.9624079875982161
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.0147059	0.9624079875982161
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.0147059	0.9624079875982161
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.0147059	0.9624079875982161
#104290 ALTERNATING HEMIPLEGIA OF CHILDHOOD 1; AHC1	0.0147059	0.9624079875982161
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.0147059	0.9624079875982161
EPILEPSY, BENIGN NEONATAL, 3	0.0147059	0.9624079875982161
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.0147059	0.9624079875982161
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.0147059	0.9624079875982161
MYOCLONIC EPILEPSY, JUVENILE, 2	0.0147059	0.9624079875982161
#607876 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 2; FAME2;;BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY 2; BAFME2;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 2; FCMTE2;;CORTICAL MYOCLONUS AND EPILEPSY, AUTOSOMAL DOMINANT; ADCME	0.0147059	0.9624079875982161
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.0147059	0.9624079875982161
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.0147059	0.9624079875982161
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.0147059	0.9624079875982161
#613603 CHROMOSOME 4q32.1-q32.2 TRIPLICATION SYNDROME	0.014596162	0.9552263307296768
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.014554992999999999	0.9525320805007598
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.014554992999999999	0.9525320805007598
#230000 FUCOSIDOSIS;;ALPHA-L-FUCOSIDASE DEFICIENCY	0.014429250999999999	0.9443030632235733
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.014429250999999999	0.9443030632235733
COFFIN-SIRIS SYNDROME 8; CSS8	0.014429250999999999	0.9443030632235733
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa; CDG2A	0.014429250999999999	0.9443030632235733
#615297 ADAMS-OLIVER SYNDROME 4; AOS4	0.0144139	0.9432984375279261
OMODYSPLASIA 1; OMOD1	0.0144139	0.9432984375279261
CHARGE SYNDROME	0.0144139	0.9432984375279261
#201000 CARPENTER SYNDROME 1; CRPT1;;CARPENTER SYNDROME;;ACROCEPHALOPOLYSYNDACTYLY TYPE II;;ACPS II	0.0144139	0.9432984375279261
FLOATING-HARBOR SYNDROME	0.0144139	0.9432984375279261
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.014357382	0.939599692490691
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.014357382	0.939599692490691
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.014357382	0.939599692490691
CHOPS SYNDROME; CHOPS	0.014357382	0.939599692490691
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.0142857	0.9349085597230932
PALMOPLANTAR KERATODERMA AND WOOLLY HAIR; PPKWH	0.0142857	0.9349085597230932
129540 ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE ANDPREAXIAL POLYDACTYLY OF FEET	0.0142857	0.9349085597230932
SPASTIC PARAPLEGIA 13, AUTOSOMAL DOMINANT	0.0142857	0.9349085597230932
ECTODERMAL DYSPLASIA WITH NATAL TEETH, TURNPENNY TYPE	0.0142857	0.9349085597230932
ECTODERMAL DYSPLASIA 10B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD10B	0.0142857	0.9349085597230932
MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1	0.0142857	0.9349085597230932
NOONAN SYNDROME 10; NS10	0.0142857	0.9349085597230932
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 11; ARCI11	0.0142857	0.9349085597230932
#604187 SPASTIC PARAPLEGIA 10, AUTOSOMAL DOMINANT; SPG10;;SPASTIC PARAPLEGIA 10 WITH OR WITHOUT PERIPHERAL NEUROPATHY	0.0142857	0.9349085597230932
CARTILAGE-HAIR HYPOPLASIA; CHH	0.0142857	0.9349085597230932
HAIR DEFECT WITH PHOTOSENSITIVITY AND MENTAL RETARDATION	0.0142857	0.9349085597230932
207720 APNEA, CENTRAL SLEEP;;SLEEP APNEA, LETHAL CENTRAL	0.0142857	0.9349085597230932
CHIARI MALFORMATION TYPE I	0.0142857	0.9349085597230932
SPINOCEREBELLAR ATAXIA 48; SCA48	0.0142857	0.9349085597230932
HYPOTRICHOSIS 8; HYPT8	0.0142857	0.9349085597230932
NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS	0.0142857	0.9349085597230932
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.0142857	0.9349085597230932
#603563 SPASTIC PARAPLEGIA 8, AUTOSOMAL DOMINANT; SPG8	0.0142857	0.9349085597230932
SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION	0.0142857	0.9349085597230932
NAXOS DISEASE; NXD	0.0142857	0.9349085597230932
NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	0.0142857	0.9349085597230932
#129500 CLOUSTON SYNDROME;;ECTODERMAL DYSPLASIA 2, CLOUSTON TYPE; ECTD2;;ECTODERMAL DYSPLASIA, HIDROTIC, AUTOSOMAL DOMINANT;;CLOUSTON HIDROTIC ECTODERMAL DYSPLASIA;;ECTODERMAL DYSPLASIA, HIDROTIC, 2, FORMERLY; HED2, FORMERLY	0.0142857	0.9349085597230932
#615896 HYPOTRICHOSIS 13; HYPT13;;HYPOTRICHOSIS WITH WOOLLY HAIR	0.0142857	0.9349085597230932
%611945 SPASTIC PARAPLEGIA 37, AUTOSOMAL DOMINANT; SPG37	0.0142857	0.9349085597230932
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.0142857	0.9349085597230932
PACHYONYCHIA CONGENITA 2	0.0142857	0.9349085597230932
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.0142857	0.9349085597230932
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND CILIARYDYSKINESIA	0.0142857	0.9349085597230932
INDIFFERENCE TO PAIN, CONGENITAL, AUTOSOMAL RECESSIVE; CIP	0.0142857	0.9349085597230932
SPASTIC PARAPLEGIA 19, AUTOSOMAL DOMINANT	0.0142857	0.9349085597230932
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.0142857	0.9349085597230932
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIB; HSAN2B	0.0142857	0.9349085597230932
SPASTIC PARAPLEGIA 36, AUTOSOMAL DOMINANT; SPG36	0.0142857	0.9349085597230932
SPINOCEREBELLAR ATAXIA 42	0.0142857	0.9349085597230932
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.0142857	0.9349085597230932
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	0.0142857	0.9349085597230932
AMYOTROPHIC DYSTONIC PARAPLEGIA	0.0142857	0.9349085597230932
#182601 SPASTIC PARAPLEGIA 4, AUTOSOMAL DOMINANT; SPG4;;FAMILIAL SPASTIC PARAPLEGIA, AUTOSOMAL DOMINANT, 2; FSP2	0.0142857	0.9349085597230932
SPASTIC PARAPLEGIA 29, AUTOSOMAL DOMINANT	0.0142857	0.9349085597230932
HYPOTRICHOSIS 7; HYPT7	0.0142857	0.9349085597230932
PEROXISOME BIOGENESIS DISORDER 14B	0.0142857	0.9349085597230932
KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, X-LINKED; KFSDX	0.0142857	0.9349085597230932
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.0142857	0.9349085597230932
190360 TRICHODYSPLASIA-XERODERMA	0.0142857	0.9349085597230932
#148210 KERATITIS-ICHTHYOSIS-DEAFNESS SYNDROME, AUTOSOMAL DOMINANT;;KID SYNDROME, AUTOSOMAL DOMINANT	0.0142857	0.9349085597230932
MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO	0.0142857	0.9349085597230932
SYRINGOMYELIA, ISOLATED	0.0142857	0.9349085597230932
CAMPTOBRACHYDACTYLY	0.0142857	0.9349085597230932
MARIE UNNA HEREDITARY HYPOTRICHOSIS 1	0.0142857	0.9349085597230932
#607259 SPASTIC PARAPLEGIA 7, AUTOSOMAL RECESSIVE; SPG7	0.0142857	0.9349085597230932
BARBER-SAY SYNDROME; BBRSAY	0.0142857	0.9349085597230932
SPASTIC PARAPLEGIA 12, AUTOSOMAL DOMINANT	0.0142857	0.9349085597230932
MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA	0.0142857	0.9349085597230932
ODONTOONYCHODERMAL DYSPLASIA; OODD	0.0142857	0.9349085597230932
ECTODERMAL DYSPLASIA, ECTRODACTYLY, AND MACULAR DYSTROPHY SYNDROME	0.0142857	0.9349085597230932
#129490 ECTODERMAL DYSPLASIA 10A, HYPOHIDROTIC/HAIR/NAIL TYPE, AUTOSOMAL DOMINANT;ECTD10A;;ECTODERMAL DYSPLASIA, HYPOHIDROTIC, AUTOSOMAL DOMINANT; HED	0.0142857	0.9349085597230932
CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME; CLPED1	0.0142857	0.9349085597230932
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.0142857	0.9349085597230932
ECTODERMAL DYSPLASIA 7, HAIR/NAIL TYPE; ECTD7	0.0142857	0.9349085597230932
#182600 SPASTIC PARAPLEGIA 3, AUTOSOMAL DOMINANT; SPG3A;;SPG3;;STRUMPELL DISEASE;;FAMILIAL SPASTIC PARAPLEGIA, AUTOSOMAL DOMINANT, 1; FSP1	0.0142857	0.9349085597230932
#607903 HYPOTRICHOSIS 6; HYPT6;;HYPOTRICHOSIS, LOCALIZED, AUTOSOMAL RECESSIVE 1; LAH1;;HYPOTRICHOSIS, LOCALIZED, AUTOSOMAL RECESSIVE; LAH;;HTL	0.0142857	0.9349085597230932
STORM SYNDROME	0.0142857	0.9349085597230932
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.0142857	0.9349085597230932
SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	0.0142857	0.9349085597230932
SANDHOFF DISEASE	0.0142857	0.9349085597230932
SPASTIC PARAPLEGIA 76, AUTOSOMAL RECESSIVE	0.0142857	0.9349085597230932
METACHROMATIC LEUKODYSTROPHY, ADULT-ONSET, WITH NORMAL ARYLSULFATASEA	0.0142857	0.9349085597230932
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.0142857	0.9349085597230932
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	0.0142857	0.9349085597230932
NOONAN SYNDROME 4; NS4	0.0142857	0.9349085597230932
#602540 ICHTHYOSIS, HYSTRIX-LIKE, WITH DEAFNESS;;HID SYNDROME	0.0142857	0.9349085597230932
KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, AUTOSOMAL DOMINANT; KFSD	0.0142857	0.9349085597230932
ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 1	0.0142857	0.9349085597230932
KAPUR-TORIELLO SYNDROME	0.014267110999999999	0.9336920274413925
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.014195242	0.92898865670851
COFFIN-SIRIS SYNDROME 6; CSS6	0.014195242	0.92898865670851
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.013954733	0.9132488663733889
TEMTAMY SYNDROME; TEMTYS	0.013954733	0.9132488663733889
BARAITSER-WINTER SYNDROME 1; BRWS1	0.013954733	0.9132488663733889
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.013954733	0.9132488663733889
CHROMOSOME 2q37 DELETION SYNDROME	0.013954733	0.9132488663733889
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.013954733	0.9132488663733889
MACDERMOT-WINTER SYNDROME	0.013954733	0.9132488663733889
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.013954733	0.9132488663733889
HOLOPROSENCEPHALY 7	0.013937713000000001	0.9121350152014835
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.013937713000000001	0.9121350152014835
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.013536793	0.8858973411803167
CHROMOSOME 10Q26 DELETION SYNDROME	0.013536793	0.8858973411803167
BOHRING-OPITZ SYNDROME	0.013536793	0.8858973411803167
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.013536793	0.8858973411803167
KOOLEN-DE VRIES SYNDROME; KDVS	0.013536793	0.8858973411803167
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.013536793	0.8858973411803167
#273750 THREE M SYNDROME 1; 3M1;;3@M SYNDROME;;LE MERRER SYNDROME;;DOLICHOSPONDYLIC DYSPLASIA;;GLOOMY FACE SYNDROMEYAKUT SHORT STATURE SYNDROME, INCLUDED	0.0135135	0.8843729619002233
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 45; MRT45	0.0135135	0.8843729619002233
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.0135135	0.8843729619002233
DEAFNESS, X-LINKED 7; DFNX7	0.0135135	0.8843729619002233
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.0135135	0.8843729619002233
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.0135135	0.8843729619002233
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.0135135	0.8843729619002233
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE; MAHCC	0.013488033	0.8827063080932368
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.013488033	0.8827063080932368
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.013253932999999999	0.8673859462046924
#269921 SIALURIA;;SIALURIA, FRENCH TYPE	0.013253932999999999	0.8673859462046924
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.013253932999999999	0.8673859462046924
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.013253932999999999	0.8673859462046924
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.013110851	0.8580221357829212
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.013110851	0.8580221357829212
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.013110851	0.8580221357829212
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.013110851	0.8580221357829212
BARAITSER-WINTER SYNDROME 2; BRWS2	0.013110851	0.8580221357829212
JOUBERT SYNDROME 1	0.013038982000000001	0.8533187650500387
CHROMOSOME 22q11.2 DELETION SYNDROME, DISTAL	0.013038982000000001	0.8533187650500387
JOUBERT SYNDROME 35; JBTS35	0.013038982000000001	0.8533187650500387
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.013038982000000001	0.8533187650500387
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.013038982000000001	0.8533187650500387
3MC SYNDROME 2	0.013038982000000001	0.8533187650500387
#608233 HERMANSKY-PUDLAK SYNDROME 2; HPS2	0.012795359999999999	0.8373752485869419
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.012692911000000001	0.8306706105898491
FRONTOOCULAR SYNDROME	0.012621041999999999	0.8259672398569666
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.012621041999999999	0.8259672398569666
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.012621041999999999	0.8259672398569666
OROFACIODIGITAL SYNDROME XIV; OFD14	0.012621041999999999	0.8259672398569666
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.012621041999999999	0.8259672398569666
JOUBERT SYNDROME 2	0.012572282	0.8227762067698867
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.012469833	0.8160715687727936
#603387 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME;MPPH;;MEGALENCEPHALY, POLYMICROGYRIA, MEGA CORPUS CALLOSUM SYNDROME;;MEG-PMG-MEGACC SYNDROME;;MEGALENCEPHALY, MEGA CORPUS CALLOSUM, AND COMPLETE LACK OF MOTOR DEVELOPMENT	0.012469833	0.8160715687727936
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.012469833	0.8160715687727936
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.012410050999999998	0.8121592156142247
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.012410050999999998	0.8121592156142247
CHROMOSOME 15q13.3 MICRODELETION SYNDROME	0.012410050999999998	0.8121592156142247
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.012410050999999998	0.8121592156142247
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.012410050999999998	0.8121592156142247
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.012410050999999998	0.8121592156142247
#252930 MUCOPOLYSACCHARIDOSIS TYPE IIIC;;MPS IIIC; MPS3C;;SANFILIPPO SYNDROME C;;ACETYL-CoA:ALPHA-GLUCOSAMINIDE N-ACETYLTRANSFERASE DEFICIENCY	0.012410050999999998	0.8121592156142247
EPILEPSY-TELANGIECTASIA	0.012410050999999998	0.8121592156142247
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.012410050999999998	0.8121592156142247
BARATELA-SCOTT SYNDROME	0.012338182	0.8074558448813425
DESBUQUOIS DYSPLASIA 2; DBQD2	0.012338182	0.8074558448813425
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.012338182	0.8074558448813425
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.012338182	0.8074558448813425
#615541 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 39; MRT39	0.012338182	0.8074558448813425
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3B	0.0121951	0.798092034459571
3MC SYNDROME 3	0.0121951	0.798092034459571
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0121951	0.798092034459571
ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	0.0121951	0.798092034459571
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.0121951	0.798092034459571
TEEBI-SHALTOUT SYNDROME; TBSH	0.0121951	0.798092034459571
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.0121951	0.798092034459571
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.01177716	0.770740509266499
SIFRIM-HITZ-WEISS SYNDROME	0.01177716	0.770740509266499
ALAGILLE SYNDROME 1; ALGS1	0.01177716	0.770740509266499
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.011660623	0.7631139009221791
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.011660623	0.7631139009221791
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.011660623	0.7631139009221791
#236250 HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATEREDUCTASE ACTIVITY;;METHYLENETETRAHYDROFOLATE REDUCTASE DEFICIENCY;;MTHFR DEFICIENCYMTHFR DEFICIENCY, THERMOLABILE TYPE, INCLUDED	0.011660623	0.7631139009221791
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.011660623	0.7631139009221791
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.011660623	0.7631139009221791
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.011660623	0.7631139009221791
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.011660623	0.7631139009221791
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.011625950999999999	0.760844838182326
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.011625950999999999	0.760844838182326
#309801 MICROPHTHALMIA, SYNDROMIC 7; MCOPS7;;MICROPHTHALMIA WITH LINEAR SKIN DEFECTS; MLS;;MICROPHTHALMIA, DERMAL APLASIA, AND SCLEROCORNEA;;MIDAS SYNDROME	0.011625950999999999	0.760844838182326
RITSCHER-SCHINZEL SYNDROME 1	0.011554082	0.7561414674494435
COSTELLO SYNDROME; CSTLO	0.011554082	0.7561414674494435
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.011554082	0.7561414674494435
#148820 WAARDENBURG SYNDROME, TYPE 3; WS3;;WAARDENBURG SYNDROME WITH UPPER LIMB ANOMALIES;;WAARDENBURG SYNDROME, TYPE III;;KLEIN-WAARDENBURG SYNDROME	0.011494299999999999	0.7522291142908748
TRANSALDOLASE DEFICIENCY	0.011494299999999999	0.7522291142908748
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.011494299999999999	0.7522291142908748
MENTAL RETARDATION, X-LINKED 97; MRX97	0.011494299999999999	0.7522291142908748
BOSMA ARHINIA MICROPHTHALMIA SYNDROME	0.011494299999999999	0.7522291142908748
LICHTENSTEIN SYNDROME	0.011494299999999999	0.7522291142908748
MENTAL RETARDATION, X-LINKED 73	0.011494299999999999	0.7522291142908748
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.011494299999999999	0.7522291142908748
#190440 TRIGONOCEPHALY 1; TRIGNO1;;CRANIOSYNOSTOSIS, METOPIC	0.011494299999999999	0.7522291142908748
9q subtelomeric deletion syndrome	0.011494299999999999	0.7522291142908748
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.011494299999999999	0.7522291142908748
PRIMROSE SYNDROME; PRIMS	0.011494299999999999	0.7522291142908748
HYPEREKPLEXIA 4; HKPX4	0.011018893	0.7211167380228392
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.011018893	0.7211167380228392
WEAVER SYNDROME	0.011018893	0.7211167380228392
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.011018893	0.7211167380228392
CATEL-MANZKE SYNDROME; CATMANS	0.011018893	0.7211167380228392
#222448 DONNAI-BARROW SYNDROME;;FACIOOCULOACOUSTICORENAL SYNDROME;;DBS/FOAR SYNDROME;;DIAPHRAGMATIC HERNIA, EXOMPHALOS, ABSENT CORPUS CALLOSUM, HYPERTELORISM,MYOPIA, SENSORINEURAL DEAFNESS, AND PROTEINURIA	0.011018893	0.7211167380228392
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.011018893	0.7211167380228392
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.011018893	0.7211167380228392
DIGEORGE SYNDROME; DGS	0.011018893	0.7211167380228392
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.011018893	0.7211167380228392
CHOREOATHETOSIS, FAMILIAL INVERTED	0.010816741	0.7078871703317114
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.010816741	0.7078871703317114
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.010816741	0.7078871703317114
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.010816741	0.7078871703317114
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.010816741	0.7078871703317114
COCKAYNE SYNDROME A; CSA	0.010816741	0.7078871703317114
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.010816741	0.7078871703317114
KUFOR-RAKEB SYNDROME	0.010816741	0.7078871703317114
ALZHEIMER DISEASE 3; AD	0.010816741	0.7078871703317114
HYPERMANGANESEMIA WITH DYSTONIA 2	0.010744872	0.703183799598829
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.010744872	0.703183799598829
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.010744872	0.703183799598829
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.010744872	0.703183799598829
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.010744872	0.703183799598829
JOUBERT SYNDROME 24	0.010744872	0.703183799598829
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.010744872	0.703183799598829
MECKEL SYNDROME, TYPE 4; MKS4	0.0107102	0.7009147368589759
JACOBSEN SYNDROME	0.0107102	0.7009147368589759
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.0107102	0.7009147368589759
ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	0.0107102	0.7009147368589759
MENTAL RETARDATION, BUENOS AIRES TYPE	0.0107102	0.7009147368589759
ROBERTS SYNDROME; RBS	0.0107102	0.7009147368589759
ACROCALLOSAL SYNDROME; ACLS	0.010175011	0.6658900074323715
ADAMS-OLIVER SYNDROME 5; AOS5	0.010175011	0.6658900074323715
SMITH-KINGSMORE SYNDROME; SKS	0.010175011	0.6658900074323715
CRANIOFRONTONASAL SYNDROME; CFNS	0.010103142	0.6611866366994891
#268310 ROBINOW SYNDROME, AUTOSOMAL RECESSIVE; RRS;;COSTOVERTEBRAL SEGMENTATION DEFECT WITH MESOMELIA, FORMERLY;;COVESDEM SYNDROME, FORMERLYROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH APLASIA/HYPOPLASIA OFPHALANGES AND METACARPALS/METATARSALS, INCLUDED;;ROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH BRACHY-SYN-POLYDACTYLY,INCLUDED	0.010103142	0.6611866366994891
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.010103142	0.6611866366994891
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.010103142	0.6611866366994891
#300555 DENT DISEASE 2	0.010103142	0.6611866366994891
TOWNES-BROCKS SYNDROME 1; TBS1	0.010103142	0.6611866366994891
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.010103142	0.6611866366994891
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.009956353	0.6515802266129554
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.009956353	0.6515802266129554
HOLOPROSENCEPHALY 2; HPE2	0.009956353	0.6515802266129554
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.009956353	0.6515802266129554
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.009956353	0.6515802266129554
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.009956353	0.6515802266129554
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.009956353	0.6515802266129554
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.009956353	0.6515802266129554
Xq28 (MECP2) duplication	0.009956353	0.6515802266129554
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.009956353	0.6515802266129554
CHROMOSOME 19p13.13 DELETION SYNDROME	0.009956353	0.6515802266129554
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.009956353	0.6515802266129554
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.009956353	0.6515802266129554
PROPIONIC ACIDEMIA	0.009956353	0.6515802266129554
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.009956353	0.6515802266129554
ANGELMAN SYNDROME	0.009956353	0.6515802266129554
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.009956353	0.6515802266129554
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.009956353	0.6515802266129554
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.009956353	0.6515802266129554
#609161 STRIATAL DEGENERATION, AUTOSOMAL DOMINANT; ADSD	0.00990099	0.6479570690083614
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.00990099	0.6479570690083614
DYSTONIA 16; DYT16	0.00990099	0.6479570690083614
#601455 CHARCOT-MARIE-TOOTH DISEASE, TYPE 4D; CMT4D;;NEUROPATHY, HEREDITARY MOTOR AND SENSORY, LOM TYPE; HMSNL;;CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, AUTOSOMAL RECESSIVE, TYPE4D;;CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 4D;;HMSN4D	0.00990099	0.6479570690083614
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1	0.00990099	0.6479570690083614
NONAKA MYOPATHY	0.00990099	0.6479570690083614
%300158 ARTHROGRYPOSIS, CONGENITAL, LOWER LIMB, X-LINKED; ACLLX;;ARTHROGRYPOSIS, X-LINKED, TYPE V, FORMERLY; AMCX5, FORMERLY	0.00990099	0.6479570690083614
#608030 AMYOTROPHIC LATERAL SCLEROSIS 6, WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA;ALS6AMYOTROPHIC LATERAL SCLEROSIS 6, AUTOSOMAL RECESSIVE, INCLUDED	0.00990099	0.6479570690083614
#164300 OCULOPHARYNGEAL MUSCULAR DYSTROPHY; OPMD;;MUSCULAR DYSTROPHY, OCULOPHARYNGEAL	0.00990099	0.6479570690083614
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J	0.00990099	0.6479570690083614
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 5	0.00990099	0.6479570690083614
MELNICK-NEEDLES SYNDROME	0.00990099	0.6479570690083614
MYOPATHY, DISTAL, 1; MPD1	0.00990099	0.6479570690083614
NEMALINE MYOPATHY 6	0.00990099	0.6479570690083614
MENTAL RETARDATION, X-LINKED 12; MRX12	0.00990099	0.6479570690083614
MOEBIUS SYNDROME; MBS	0.00990099	0.6479570690083614
EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3	0.00990099	0.6479570690083614
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.00990099	0.6479570690083614
MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16	0.00990099	0.6479570690083614
#600116 PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE; PARK2;;PARKINSON DISEASE, JUVENILE, AUTOSOMAL RECESSIVE; PDJ;;PARKINSONISM, EARLY-ONSET, WITH DIURNAL FLUCTUATION; EPDF	0.00990099	0.6479570690083614
#615156 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS,AUTOSOMAL DOMINANT, 6; PEOA6;;PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL DOMINANT, 6	0.00990099	0.6479570690083614
MYASTHENIC SYNDROME, CONGENITAL, 7, PRESYNAPTIC; CMS7	0.00990099	0.6479570690083614
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2EE; CMT2EE	0.00990099	0.6479570690083614
TREMOR, HEREDITARY ESSENTIAL, AND IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS	0.00990099	0.6479570690083614
MAST SYNDROME	0.00990099	0.6479570690083614
BARTH SYNDROME; BTHS	0.00990099	0.6479570690083614
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5	0.00990099	0.6479570690083614
BEHR SYNDROME	0.00990099	0.6479570690083614
NEMALINE MYOPATHY 7; NEM7	0.00990099	0.6479570690083614
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4; LGMDD4	0.00990099	0.6479570690083614
#118700 CHOREA, BENIGN HEREDITARY; BHC;;BCH;;HEREDITARY PROGRESSIVE CHOREA WITHOUT DEMENTIA	0.00990099	0.6479570690083614
SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE; SPG43	0.00990099	0.6479570690083614
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, OKINAWA TYPE; HMSNO	0.00990099	0.6479570690083614
DYSTONIA 23; DYT23	0.00990099	0.6479570690083614
#612020 SPASTIC PARAPLEGIA 39, AUTOSOMAL RECESSIVE; SPG39;;NTE-RELATED MOTOR NEURON DISORDER; NTEMND	0.00990099	0.6479570690083614
%271630 BRACHYOLMIA TYPE 1, TOLEDO TYPE;;SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, TOLEDO TYPE;;SED, CHONDROITIN SULFATE TYPE;;PAPS-CHONDROITIN SULFATE SULFOTRANSFERASE DEFICIENCY	0.00990099	0.6479570690083614
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.00990099	0.6479570690083614
224550 DYSTONIA WITH RINGBINDEN	0.00990099	0.6479570690083614
CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY	0.00990099	0.6479570690083614
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00990099	0.6479570690083614
TRYPTOPHANURIA WITH DWARFISM	0.00990099	0.6479570690083614
SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1	0.00990099	0.6479570690083614
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.00990099	0.6479570690083614
SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT; SPG80	0.00990099	0.6479570690083614
Lipodystrophy, congenital generalized, type 2	0.00925926	0.6059599061090215
EHLERS-DANLOS SYNDROME, TYPE I	0.00925926	0.6059599061090215
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.00925926	0.6059599061090215
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.00925926	0.6059599061090215
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.00925926	0.6059599061090215
LOEYS-DIETZ SYNDROME 3; LDS3	0.00925926	0.6059599061090215
VELOCARDIOFACIAL SYNDROME	0.00925926	0.6059599061090215
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 2; EDSPD2	0.00925926	0.6059599061090215
ARTERIAL TORTUOSITY SYNDROME	0.00925926	0.6059599061090215
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.00925926	0.6059599061090215
LATERAL MENINGOCELE SYNDROME	0.00925926	0.6059599061090215
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.00925926	0.6059599061090215
MEIER-GORLIN SYNDROME 6; MGORS6	0.00925926	0.6059599061090215
MUSCULAR HYPERTONIA, LETHAL	0.00925926	0.6059599061090215
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.00925926	0.6059599061090215
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.00925926	0.6059599061090215
#265000 MULTIPLE PTERYGIUM SYNDROME, ESCOBAR VARIANT; EVMPS;;ESCOBAR SYNDROME;;MULTIPLE PTERYGIUM SYNDROME, NONLETHAL TYPE;;PTERYGIUM SYNDROME;;MULTIPLE PTERYGIUM SYNDROME;;PTERYGIUM COLLI SYNDROME;;PTERYGIUM UNIVERSALE	0.00925926	0.6059599061090215
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.00925926	0.6059599061090215
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.00925926	0.6059599061090215
HURLER-SCHEIE SYNDROME	0.00925926	0.6059599061090215
Lipodystrophy, congenital generalized, type 1	0.00925926	0.6059599061090215
GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION	0.00925926	0.6059599061090215
SCARF SYNDROME	0.00925926	0.6059599061090215
VASCULAR MALFORMATION, PRIMARY INTRAOSSEOUS	0.00925926	0.6059599061090215
#225410 EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL RECESSIVE;;EHLERS-DANLOS SYNDROME, DERMATOSPARAXIS TYPE;;DERMATOSPARAXIS;;EDS VIIC;;EDS7C	0.00925926	0.6059599061090215
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.00925926	0.6059599061090215
#278250 WRINKLY SKIN SYNDROME; WSS	0.00925926	0.6059599061090215
HYPOPHOSPHATASIA, INFANTILE	0.009112470999999999	0.5963534960224878
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.009112470999999999	0.5963534960224878
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.009112470999999999	0.5963534960224878
RETT SYNDROME, CONGENITAL VARIANT	0.009112470999999999	0.5963534960224878
RETT SYNDROME; RTT	0.009112470999999999	0.5963534960224878
AUTISM, SUSCEPTIBILITY TO, 18	0.009112470999999999	0.5963534960224878
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.009112470999999999	0.5963534960224878
GITELMAN SYNDROME	0.009112470999999999	0.5963534960224878
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.009112470999999999	0.5963534960224878
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.009112470999999999	0.5963534960224878
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.009040602	0.5916501252896054
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.009040602	0.5916501252896054
300270 ADRENOMYODYSTROPHY	0.009040602	0.5916501252896054
NIEMANN-PICK DISEASE, TYPE A	0.009040602	0.5916501252896054
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.009040602	0.5916501252896054
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.009040602	0.5916501252896054
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.008382153	0.5485588097614121
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.008382153	0.5485588097614121
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.008382153	0.5485588097614121
MENTAL RETARDATION, X-LINKED 90	0.008382153	0.5485588097614121
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.008382153	0.5485588097614121
#231050 GELEOPHYSIC DYSPLASIA 1; GPHYSD1	0.008382153	0.5485588097614121
CHROMOSOME 1q41-q42 DELETION SYNDROME	0.008382153	0.5485588097614121
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.008382153	0.5485588097614121
C SYNDROME	0.008382153	0.5485588097614121
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.008382153	0.5485588097614121
PRADER-WILLI SYNDROME; PWS	0.008382153	0.5485588097614121
CHROMOSOME 22q13 DUPLICATION SYNDROME	0.008382153	0.5485588097614121
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.008382153	0.5485588097614121
#300831 CK SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH THIN BODY HABITUS AND CORTICALMALFORMATION	0.008382153	0.5485588097614121
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.008382153	0.5485588097614121
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.008382153	0.5485588097614121
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.008382153	0.5485588097614121
WIEACKER-WOLFF SYNDROME	0.008382153	0.5485588097614121
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7	0.00819672	0.5364233946991377
#600072 FATAL FAMILIAL INSOMNIA; FFI;;INSOMNIA, FATAL FAMILIAL	0.00819672	0.5364233946991377
SACRAL DEFECT WITH ANTERIOR MENINGOCELE	0.00819672	0.5364233946991377
MYXEDEMA	0.00819672	0.5364233946991377
%193250 VOLVULUS OF MIDGUT;;INTESTINAL MALROTATION, FAMILIAL	0.00819672	0.5364233946991377
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.00819672	0.5364233946991377
ANAL SPHINCTER DYSPLASIA; ASDP	0.00819672	0.5364233946991377
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.00819672	0.5364233946991377
VISCERAL MYOPATHY; VSCM	0.00819672	0.5364233946991377
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.00819672	0.5364233946991377
#308940 LEIOMYOMATOSIS, DIFFUSE, WITH ALPORT SYNDROME; DL-ATS;;LEIOMYOMATOSIS, ESOPHAGEAL AND VULVAL, WITH NEPHROPATHY;;ALPORT SYNDROME AND DIFFUSE LEIOMYOMATOSIS; ATS-DL;;CHROMOSOME Xq22.3 CENTROMERIC DELETION SYNDROME	0.00819672	0.5364233946991377
FG SYNDROME 2; FGS2	0.00819672	0.5364233946991377
UROFACIAL SYNDROME	0.00819672	0.5364233946991377
ANAL SPHINCTER MYOPATHY, INTERNAL	0.00819672	0.5364233946991377
ADIPOSIS DOLOROSA	0.00819672	0.5364233946991377
PORPHYRIA VARIEGATA	0.00819672	0.5364233946991377
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.00819672	0.5364233946991377
MYOPATHY, MYOFIBRILLAR, 1; MFM1	0.00819672	0.5364233946991377
#226600 EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE; RDEB;;DYSTROPHIC EPIDERMOLYSIS BULLOSA, AUTOSOMAL RECESSIVE;;EPIDERMOLYSIS BULLOSA DYSTROPHICA, HALLOPEAU-SIEMENS TYPE; EBR1EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE, LOCALISATAVARIANT, INCLUDED;;EPIDERMOLYSIS BULLOSA DYSTROPHICA INVERSA, AUTOSOMAL RECESSIVE, INCLUDED	0.00819672	0.5364233946991377
#121300 COPROPORPHYRIA, HEREDITARY; HCP;;COPROPORPHYRINOGEN OXIDASE DEFICIENCY;;CPOX DEFICIENCY;;CPO DEFICIENCY;;CPX DEFICIENCYHARDEROPORPHYRIA, INCLUDED	0.00819672	0.5364233946991377
DIASTASIS RECTI AND WEAKNESS OF THE LINEA ALBA	0.00819672	0.5364233946991377
PARKINSON DISEASE, LATE-ONSET; PD	0.00819672	0.5364233946991377
HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; HSCR1	0.00819672	0.5364233946991377
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00819672	0.5364233946991377
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6	0.00819672	0.5364233946991377
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.00819672	0.5364233946991377
THYROTROPIN-RELEASING HORMONE DEFICIENCY	0.00819672	0.5364233946991377
UROFACIAL SYNDROME 2	0.00819672	0.5364233946991377
#606764 GASTROINTESTINAL STROMAL TUMOR; GIST	0.00819672	0.5364233946991377
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.007932473	0.5191301026531654
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.007932473	0.5191301026531654
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.007932473	0.5191301026531654
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii; CDG1I	0.007932473	0.5191301026531654
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.007932472999999999	0.5191301026531653
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.007932472999999999	0.5191301026531653
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.007932472999999999	0.5191301026531653
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.007932472999999999	0.5191301026531653
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.007932472999999999	0.5191301026531653
Helsmoortel-van der Aa syndrome	0.007932472999999999	0.5191301026531653
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.007932472999999999	0.5191301026531653
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.007932472999999999	0.5191301026531653
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.007932472999999999	0.5191301026531653
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.007932472999999999	0.5191301026531653
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.007932472999999999	0.5191301026531653
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.007932472999999999	0.5191301026531653
HEART AND BRAIN MALFORMATION SYNDROME	0.007932472999999999	0.5191301026531653
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.007932472999999999	0.5191301026531653
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.007932472999999999	0.5191301026531653
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.007538271	0.4933320791709445
#215100 RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1; RCDP1;;PEROXISOME BIOGENESIS DISORDER 9; PBD9;;CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC FORM; CDPR;;CHONDRODYSTROPHIA CALCIFICANS PUNCTATA	0.007538271	0.4933320791709445
#300534 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE; MRXSCJ;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, JARID1C-RELATED; MRXSJ	0.007538271	0.4933320791709445
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.007538271	0.4933320791709445
BRANCHIOOCULOFACIAL SYNDROME	0.007538271	0.4933320791709445
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.007538271	0.4933320791709445
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.007538271	0.4933320791709445
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.007538271	0.4933320791709445
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.007538271	0.4933320791709445
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIe; CDG2E	0.007538271	0.4933320791709445
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.007538271	0.4933320791709445
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.007466402	0.488628708438062
MENTAL RETARDATION, X-LINKED 107; MRX107	0.007466402	0.488628708438062
XIA-GIBBS SYNDROME	0.007466402	0.488628708438062
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.007466402	0.488628708438062
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.007466402	0.488628708438062
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.007466402	0.488628708438062
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.007466402	0.488628708438062
CHROMOSOME 10q22.3-q23.2 DELETION SYNDROME	0.007466402	0.488628708438062
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.007466402	0.488628708438062
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.007466402	0.488628708438062
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.007466402	0.488628708438062
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIg; CDG2G	0.007466402	0.488628708438062
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.007466402	0.488628708438062
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.007466402	0.488628708438062
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.007466402	0.488628708438062
CHROMOSOME 16Q22 DELETION SYNDROME	0.007466402	0.488628708438062
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.007466402	0.488628708438062
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.007466402	0.488628708438062
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.007315193	0.4787330373538891
MELANOSIS, NEUROCUTANEOUS; NCMS	0.007315193	0.4787330373538891
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.007315193	0.4787330373538891
INFANTILE SIALIC ACID STORAGE DISEASE	0.007315193	0.4787330373538891
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.007315193	0.4787330373538891
GRACILE BONE DYSPLASIA; GCLEB	0.007315193	0.4787330373538891
MEND SYNDROME; MEND	0.007315193	0.4787330373538891
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.007315193	0.4787330373538891
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.007315193	0.4787330373538891
#610829 HOLOPROSENCEPHALY 9; HPE9;;PITUITARY ANOMALIES WITH HOLOPROSENCEPHALY-LIKE FEATURES;;HOLOPROSENCEPHALY WITH MICROPHTHALMIA AND FIRST BRANCHIAL ARCH ANOMALIES	0.007315193	0.4787330373538891
PETTIGREW SYNDROME	0.007315193	0.4787330373538891
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.007315193	0.4787330373538891
#300886 MENTAL RETARDATION, X-LINKED, SYNDROMIC 32; MRXS32	0.007315193	0.4787330373538891
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.007315193	0.4787330373538891
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.007315193	0.4787330373538891
BAND HETEROTOPIA; BH	0.007315193	0.4787330373538891
#602398 DESMOSTEROLOSIS	0.007315193	0.4787330373538891
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.007315193	0.4787330373538891
MIRAGE SYNDROME; MIRAGE	0.007315193	0.4787330373538891
FILIPPI SYNDROME; FLPIS	0.007088591	0.4639033720626977
#252011 MITOCHONDRIAL COMPLEX II DEFICIENCY;;SUCCINATE CoQ REDUCTASE DEFICIENCY	0.007088591	0.4639033720626977
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.007088591	0.4639033720626977
CROUZON SYNDROME	0.007088591	0.4639033720626977
#612438 LEUKODYSTROPHY, HYPOMYELINATING, 6; HLD6;;LEUKODYSTROPHY, HYPOMYELINATING, WITH ATROPHY OF THE BASAL GANGLIAAND CEREBELLUM; HABC	0.007088591	0.4639033720626977
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.007088591	0.4639033720626977
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.007088591	0.4639033720626977
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.007088591	0.4639033720626977
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.007088591	0.4639033720626977
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.007088591	0.4639033720626977
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.007088591	0.4639033720626977
#611755 LEBER CONGENITAL AMAUROSIS 10; LCA10	0.007088591	0.4639033720626977
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.0070167219999999995	0.4592000013298152
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.0070167219999999995	0.4592000013298152
#614873 PEROXISOME BIOGENESIS DISORDER 7B; PBD7B	0.0070167219999999995	0.4592000013298152
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.0070167219999999995	0.4592000013298152
HYPERTRYPTOPHANEMIA; HYPTRP	0.0070167219999999995	0.4592000013298152
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.0070167219999999995	0.4592000013298152
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.0070167219999999995	0.4592000013298152
BAKER-GORDON SYNDROME; BAGOS	0.0070167219999999995	0.4592000013298152
MUCOLIPIDOSIS IV; ML4	0.0070167219999999995	0.4592000013298152
PEROXISOME BIOGENESIS DISORDER 5B	0.0070167219999999995	0.4592000013298152
#300257 DANON DISEASE;;VACUOLAR CARDIOMYOPATHY AND MYOPATHY, X-LINKED;;PSEUDOGLYCOGENOSIS II;;ANTOPOL DISEASE;;LYSOSOMAL GLYCOGEN STORAGE DISEASE WITHOUT ACID MALTASE DEFICIENCY,FORMERLY;;GLYCOGEN STORAGE DISEASE IIb; GSD2B, FORMERLY;;GSD IIb, FORMERLY	0.0070167219999999995	0.4592000013298152
OCULOECTODERMAL SYNDROME; OES	0.006914273	0.45249536333272233
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.006914273	0.45249536333272233
#117550 SOTOS SYNDROME 1; SOTOS1;;SOTOS SYNDROME;;CEREBRAL GIGANTISM;;CHROMOSOME 5q35 DELETION SYNDROME	0.006914273	0.45249536333272233
#249270 THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME; TRMA;;THIAMINE METABOLISM DYSFUNCTION SYNDROME 1 (MEGALOBLASTIC ANEMIA,DIABETES MELLITUS, AND DEAFNESS TYPE); THMD1;;MEGALOBLASTIC ANEMIA, THIAMINE-RESPONSIVE, WITH DIABETES MELLITUSAND SENSORINEURAL DEAFNESS;;ROGERS SYNDROME;;THIAMINE-RESPONSIVE ANEMIA SYNDROME;;THIAMINE-RESPONSIVE MYELODYSPLASIA	0.006914273	0.45249536333272233
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.006914273	0.45249536333272233
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.006914273	0.45249536333272233
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.006914273	0.45249536333272233
RECOMBINANT CHROMOSOME 8 SYNDROME	0.006914273	0.45249536333272233
#274000 THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME; TAR;;TAR SYNDROME;;CHROMOSOME 1q21.1 DELETION SYNDROME, 200-KB	0.006914273	0.45249536333272233
KAGAMI-OGATA SYNDROME	0.006914273	0.45249536333272233
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.006914273	0.45249536333272233
CODAS SYNDROME	0.006914273	0.45249536333272233
ADAMS-OLIVER SYNDROME 1; AOS1	0.006914273	0.45249536333272233
CHROMOSOME 8q22.1 DUPLICATION SYNDROME	0.00662252	0.4334019778475944
#190685 DOWN SYNDROMETRISOMY 21, INCLUDED;;DOWN SYNDROME CHROMOSOME REGION, INCLUDED; DCR, INCLUDED;;DOWN SYNDROME CRITICAL REGION, INCLUDED; DSCR, INCLUDED;;TRANSIENT MYELOPROLIFERATIVE DISORDER OF DOWN SYNDROME, INCLUDED;;LEUKEMIA, MEGAKARYOBLASTIC, OF DOWN SYNDROME, INCLUDED	0.00662252	0.4334019778475944
260150 PALANT CLEFT PALATE SYNDROME	0.00662252	0.4334019778475944
#162100 AMYOTROPHY, HEREDITARY NEURALGIC; HNA;;NEURITIS WITH BRACHIAL PREDILECTION; NAPB;;BRACHIAL PLEXUS NEUROPATHY, HEREDITARY;;AMYOTROPHY, HEREDITARY NEURALGIC, WITH PREDILECTION FOR BRACHIAL PLEXUS	0.00662252	0.4334019778475944
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.00662252	0.4334019778475944
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.00662252	0.4334019778475944
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.00662252	0.4334019778475944
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.00662252	0.4334019778475944
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00662252	0.4334019778475944
FEINGOLD SYNDROME 1; FGLDS1	0.00662252	0.4334019778475944
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.00662252	0.4334019778475944
SCHOLTE SYNDROME; SHLTS	0.00662252	0.4334019778475944
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.00662252	0.4334019778475944
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.00662252	0.4334019778475944
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00662252	0.4334019778475944
MICROCEPHALY, AUTOSOMAL DOMINANT	0.00662252	0.4334019778475944
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	0.00662252	0.4334019778475944
VERVERI-BRADY SYNDROME; VERBRAS	0.00662252	0.4334019778475944
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 3; HKLLS3	0.00662252	0.4334019778475944
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.00662252	0.4334019778475944
115645 CATARACT, ABERRANT ORAL FRENULA, AND GROWTH RETARDATION	0.00662252	0.4334019778475944
NIJMEGEN BREAKAGE SYNDROME	0.00662252	0.4334019778475944
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00662252	0.4334019778475944
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.00662252	0.4334019778475944
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.006471311	0.4235063067634215
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.006471311	0.4235063067634215
#615937 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 2;MPPH2	0.006471311	0.4235063067634215
#236600 HYDROCEPHALUS, NONSYNDROMIC, AUTOSOMAL RECESSIVE 1; HYC1;;HYDROCEPHALY;;VENTRICULOMEGALY	0.006471311	0.4235063067634215
#218600 BALLER-GEROLD SYNDROME; BGS;;CRANIOSYNOSTOSIS WITH RADIAL DEFECTS;;CRANIOSYNOSTOSIS-RADIAL APLASIA SYNDROME	0.006471311	0.4235063067634215
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.006471311	0.4235063067634215
PAPILLOMA OF CHOROID PLEXUS	0.006471311	0.4235063067634215
#613150 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES), TYPE A, 2; MDDGA2;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, POMT2-RELATED	0.006471311	0.4235063067634215
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.006471311	0.4235063067634215
#604213 CHUDLEY-MCCULLOUGH SYNDROME; CMCS;;DEAFNESS, SENSORINEURAL, WITH PARTIAL AGENESIS OF THE CORPUS CALLOSUMAND ARACHNOID CYSTS;;DEAFNESS, AUTOSOMAL RECESSIVE 82; DFNB82	0.006471311	0.4235063067634215
ALEXANDER DISEASE	0.006471311	0.4235063067634215
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.006471311	0.4235063067634215
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.006471311	0.4235063067634215
KRABBE DISEASE	0.006471311	0.4235063067634215
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.006471311	0.4235063067634215
NEUROFIBROMATOSIS, TYPE I	0.006471311	0.4235063067634215
GAUCHER DISEASE, TYPE IIIC	0.006471311	0.4235063067634215
OROFACIODIGITAL SYNDROME I; OFD1	0.006471311	0.4235063067634215
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.006471311	0.4235063067634215
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.006399442	0.418802936030539
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.006399442	0.418802936030539
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.006399442	0.418802936030539
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.006399442	0.418802936030539
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.006399442	0.418802936030539
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.006399442	0.418802936030539
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.006399442	0.418802936030539
THANATOPHORIC DYSPLASIA, TYPE I	0.006399442	0.418802936030539
POPOV-CHANG SYNDROME; POPCHAS	0.006399442	0.418802936030539
#272200 MULTIPLE SULFATASE DEFICIENCY; MSD;;MUCOSULFATIDOSIS;;SULFATIDOSIS, JUVENILE, AUSTIN TYPE	0.006399442	0.418802936030539
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3	0.00617284	0.40397327073934763
#300071 NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A; CSNB2A;;CSNB, INCOMPLETE, X-LINKED;;NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2; CSNB2	0.00617284	0.40397327073934763
#258450 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS,AUTOSOMAL RECESSIVE; PEOB;;PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA, AUTOSOMAL RECESSIVE	0.00617284	0.40397327073934763
#612390 PONTOCEREBELLAR HYPOPLASIA, TYPE 2C; PCH2C	0.00617284	0.40397327073934763
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.00617284	0.40397327073934763
OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4; OPTB4	0.00617284	0.40397327073934763
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.00617284	0.40397327073934763
PANCREATITIS, SCLEROSING CHOLANGITIS, AND SICCA COMPLEX	0.00617284	0.40397327073934763
CORNEA GUTTATA WITH ANTERIOR POLAR CATARACTS	0.00617284	0.40397327073934763
BLUE CONE MONOCHROMACY; BCM	0.00617284	0.40397327073934763
RETINITIS PIGMENTOSA 27; RP27	0.00617284	0.40397327073934763
NYSTAGMUS 2, CONGENITAL, AUTOSOMAL DOMINANT; NYS2	0.00617284	0.40397327073934763
#612775 CONE-ROD DYSTROPHY 9; CORD9	0.00617284	0.40397327073934763
MACULAR DYSTROPHY, VITELLIFORM, 2; VMD2	0.00617284	0.40397327073934763
#613428 RETINITIS PIGMENTOSA 54; RP54	0.00617284	0.40397327073934763
#603649 CONE-ROD DYSTROPHY 7; CORD7	0.00617284	0.40397327073934763
#613758 RETINITIS PIGMENTOSA 47; RP47	0.00617284	0.40397327073934763
DYSKERATOSIS, HEREDITARY BENIGN INTRAEPITHELIAL; HBID	0.00617284	0.40397327073934763
PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE	0.00617284	0.40397327073934763
N SYNDROME	0.00617284	0.40397327073934763
XFE PROGEROID SYNDROME; XFEPS	0.00617284	0.40397327073934763
#165550 OPTIC NERVE HYPOPLASIA, BILATERALOPTIC NERVE APLASIA, BILATERAL, INCLUDED	0.00617284	0.40397327073934763
%258500 OPTIC ATROPHY 6; OPA6;;OPTIC ATROPHY, CONGENITAL OR EARLY INFANTILE, AUTOSOMAL RECESSIVE	0.00617284	0.40397327073934763
#608471 CORNEAL DYSTROPHY, LATTICE TYPE IIIA; CDL3A;;LATTICE CORNEAL DYSTROPHY, TYPE IIIA	0.00617284	0.40397327073934763
#258501 3-@METHYLGLUTACONIC ACIDURIA, TYPE III; MGCA3;;MGA, TYPE III; MGA3;;OPTIC ATROPHY PLUS SYNDROME;;OPTIC ATROPHY, INFANTILE, WITH CHOREA AND SPASTIC PARAPLEGIA;;IRAQI-JEWISH 'OPTIC ATROPHY PLUS';;COSTEFF SYNDROME;;OPTIC ATROPHY 3, AUTOSOMAL RECESSIVE;;OPA3, AUTOSOMAL RECESSIVE	0.00617284	0.40397327073934763
610319 RHIZOMELIC DYSPLASIA, SCOLIOSIS, AND RETINITIS PIGMENTOSA	0.00617284	0.40397327073934763
LEBER CONGENITAL AMAUROSIS 5; LCA5	0.00617284	0.40397327073934763
#606952 ALBINISM, OCULOCUTANEOUS, TYPE IB; OCA1B;;OCULOCUTANEOUS ALBINISM, TYPE IB;;ALBINISM, YELLOW MUTANT TYPE;;YELLOW ALBINISMALBINISM, OCULOCUTANEOUS, TYPE I, TEMPERATURE-SENSITIVE, INCLUDED;;OCA1-TS, INCLUDED	0.00617284	0.40397327073934763
FOVEAL HYPOPLASIA AND PRESENILE CATARACT SYNDROMEFOVEAL HYPOPLASIA, ISOLATED, INCLUDED	0.00617284	0.40397327073934763
CHROMOSOME Xp11.3 DELETION SYNDROME	0.00617284	0.40397327073934763
AUDITORY NEUROPATHY AND OPTIC ATROPHY; ANOA	0.00617284	0.40397327073934763
#613829 LEBER CONGENITAL AMAUROSIS 7; LCA7	0.00617284	0.40397327073934763
#607921 RETINITIS PIGMENTOSA 30; RP30	0.00617284	0.40397327073934763
#614180 RETINITIS PIGMENTOSA 61; RP61	0.00617284	0.40397327073934763
HERMANSKY-PUDLAK SYNDROME 8; HPS8	0.00617284	0.40397327073934763
LEBER CONGENITAL AMAUROSIS 8; LCA8	0.00617284	0.40397327073934763
BIRDSHOT CHORIORETINOPATHY	0.00617284	0.40397327073934763
RETINAL CONE DYSTROPHY 4	0.00617284	0.40397327073934763
#613827 RETINITIS PIGMENTOSA 48; RP48	0.00617284	0.40397327073934763
DOYNE HONEYCOMB RETINAL DYSTROPHY	0.00617284	0.40397327073934763
CREUTZFELDT-JAKOB DISEASE; CJD	0.00617284	0.40397327073934763
RETINITIS PIGMENTOSA 20	0.00617284	0.40397327073934763
#610427 CONE-ROD SYNAPTIC DISORDER, CONGENITAL NONPROGRESSIVE; CRSD;;NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B, FORMERLY; CSNB2B,FORMERLY;;NIGHT BLINDNESS, CONGENITAL STATIONARY, INCOMPLETE, AUTOSOMAL RECESSIVE,FORMERLY	0.00617284	0.40397327073934763
ALBINISM, OCULAR, WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00617284	0.40397327073934763
LEBER CONGENITAL AMAUROSIS 19; LCA19	0.00617284	0.40397327073934763
#613268 CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 4; FECD4;;CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, LATE-ONSET	0.00617284	0.40397327073934763
#103470 ALBINISM, OCULAR, WITH SENSORINEURAL DEAFNESS;;WAARDENBURG SYNDROME, TYPE 2, WITH OCULAR ALBINISM, AUTOSOMAL RECESSIVE;WS2-OA	0.00617284	0.40397327073934763
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.00617284	0.40397327073934763
GILLESPIE SYNDROME; GLSP	0.00617284	0.40397327073934763
#610359 RETINITIS PIGMENTOSA 33; RP33	0.00617284	0.40397327073934763
#606574 ALBINISM, OCULOCUTANEOUS, TYPE IV; OCA4;;OCULOCUTANEOUS ALBINISM, TYPE IV	0.00617284	0.40397327073934763
#304700 MOHR-TRANEBJAERG SYNDROME; MTS;;DYSTONIA-DEAFNESS SYNDROME; DDS;;DEAFNESS-DYSTONIA-OPTIC ATROPHY SYNDROME; DDP;;DEAFNESS SYNDROME, PROGRESSIVE, WITH BLINDNESS, DYSTONIA, FRACTURES,AND MENTAL DEFICIENCY	0.00617284	0.40397327073934763
#614504 USHER SYNDROME, TYPE IIIB; USH3B	0.00617284	0.40397327073934763
CONE-ROD DYSTROPHY 17; CORD17	0.00617284	0.40397327073934763
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 2; CFEOM2	0.00617284	0.40397327073934763
CHORIORETINAL ATROPHY, PROGRESSIVE BIFOCAL	0.00617284	0.40397327073934763
OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALDOMINANT	0.00617284	0.40397327073934763
HERMANSKY-PUDLAK SYNDROME 3; HPS3	0.00617284	0.40397327073934763
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 6	0.00617284	0.40397327073934763
TANGIER DISEASE; TGD	0.00617284	0.40397327073934763
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIC, WITH OPTIC ATROPHY; HMSN6C	0.00617284	0.40397327073934763
EPITHELIAL RECURRENT EROSION DYSTROPHY	0.00617284	0.40397327073934763
CONE DYSTROPHY 4	0.00617284	0.40397327073934763
258650 OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALRECESSIVE	0.00617284	0.40397327073934763
ALBINISM, OCULAR, TYPE I	0.00617284	0.40397327073934763
LEBER CONGENITAL AMAUROSIS 11; LCA11	0.00617284	0.40397327073934763
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.00617284	0.40397327073934763
#613856 ACHROMATOPSIA 4; ACHM4	0.00617284	0.40397327073934763
LEG, ABSENCE DEFORMITY OF, WITH CONGENITAL CATARACT	0.00617284	0.40397327073934763
#615431 MYOPIA 23, AUTOSOMAL RECESSIVE; MYP23	0.00617284	0.40397327073934763
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.00617284	0.40397327073934763
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00617284	0.40397327073934763
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00617284	0.40397327073934763
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.00617284	0.40397327073934763
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.0060703910000000005	0.3972686327422547
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.0060703910000000005	0.3972686327422547
#309520 LUJAN-FRYNS SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH MARFANOID HABITUS	0.0060703910000000005	0.3972686327422547
NOONAN SYNDROME 7; NS7	0.0060703910000000005	0.3972686327422547
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.0060703910000000005	0.3972686327422547
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.0060703910000000005	0.3972686327422547
FRYNS SYNDROME; FRNS	0.0060703910000000005	0.3972686327422547
GENITOPATELLAR SYNDROME; GTPTS	0.005998522	0.3925652620093722
HADZISELIMOVIC SYNDROME	0.005998522	0.3925652620093722
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.005998522	0.3925652620093722
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.005998522	0.3925652620093722
TURNPENNY-FRY SYNDROME; TPFS	0.005998522	0.3925652620093722
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.005998522	0.3925652620093722
Bardet-Biedl syndrome 2	0.005998522	0.3925652620093722
NOONAN SYNDROME 11; NS11	0.005998522	0.3925652620093722
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.005998522	0.3925652620093722
Mental retardation, autosomal dominant 21	0.005998522	0.3925652620093722
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.005998522	0.3925652620093722
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.005998522	0.3925652620093722
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.005998522	0.3925652620093722
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.005998522	0.3925652620093722
LYMPHEDEMA, HEREDITARY, III	0.005998522	0.3925652620093722
TYSHCHENKO SYNDROME	0.005998522	0.3925652620093722
SECKEL SYNDROME 9; SCKL9	0.005998522	0.3925652620093722
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.005998522	0.3925652620093722
%300712 CRANIOFACIOSKELETAL SYNDROME	0.005998522	0.3925652620093722
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.005998522	0.3925652620093722
NOONAN SYNDROME 5; NS5	0.005998522	0.3925652620093722
OROTIC ACIDURIA	0.005998522	0.3925652620093722
CHROMOSOME 17q23.1-q23.2 DELETION SYNDROME	0.005998522	0.3925652620093722
NOONAN SYNDROME 3; NS3	0.005998522	0.3925652620093722
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.005998522	0.3925652620093722
COLE-CARPENTER SYNDROME 2; CLCRP2	0.00555556	0.3635762054400714
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.00555556	0.3635762054400714
SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18	0.00555556	0.3635762054400714
CHONDRODYSPLASIA WITH PLATYSPONDYLY, DISTINCTIVE BRACHYDACTYLY, HYDROCEPHALY, AND MICROPHTHALMIA	0.00555556	0.3635762054400714
VENTRICULOMEGALY WITH DEFECTS OF THE RADIUS AND KIDNEY	0.00555556	0.3635762054400714
NEPHRONOPHTHISIS 18; NPHP18	0.00555556	0.3635762054400714
258040 OEIS COMPLEX;;OMPHALOCELE-EXSTROPHY-IMPERFORATE ANUS-SPINAL DEFECTS	0.00555556	0.3635762054400714
#101800 ACRODYSOSTOSIS 1, WITH OR WITHOUT HORMONE RESISTANCE; ACRDYS1;;ADOHR	0.00555556	0.3635762054400714
CRANIOSYNOSTOSIS, SAGITTAL, WITH DANDY-WALKER MALFORMATION AND HYDROCEPHALUS	0.00555556	0.3635762054400714
VACTERL ASSOCIATION, X-LINKED, WITH OR WITHOUT HYDROCEPHALUS; VACTERLX	0.00555556	0.3635762054400714
MEGALENCEPHALY	0.00555556	0.3635762054400714
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.00555556	0.3635762054400714
HYDROCEPHALUS, CONGENITAL, 3, WITH BRAIN ANOMALIES; HYC3	0.00555556	0.3635762054400714
OSTEOCHONDRODYSPLASIA, RHIZOMELIC, WITH CALLOSAL AGENESIS, THROMBOCYTOPENIA,HYDROCEPHALUS, AND HYPERTENSION	0.00555556	0.3635762054400714
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.00555556	0.3635762054400714
183802 SPLIT-HAND WITH OBSTRUCTIVE UROPATHY, SPINA BIFIDA, AND DIAPHRAGMATICDEFECTS	0.00555556	0.3635762054400714
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.00555556	0.3635762054400714
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.00555556	0.3635762054400714
#614120 HYDROLETHALUS SYNDROME 2; HLS2	0.00555556	0.3635762054400714
MASA SYNDROME	0.00555556	0.3635762054400714
#613154 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES), TYPE A, 6; MDDGA6;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, LARGE-RELATED	0.00555556	0.3635762054400714
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.00555556	0.3635762054400714
CHIARI MALFORMATION TYPE II	0.00555556	0.3635762054400714
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00555556	0.3635762054400714
#607361 MECKEL SYNDROME, TYPE 3; MKS3;;MECKEL-GRUBER SYNDROME, TYPE 3	0.00555556	0.3635762054400714
OMPHALOCELE-CLEFT PALATE SYNDROME, LETHAL	0.00555556	0.3635762054400714
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.00555556	0.3635762054400714
HEMIFACIAL MICROSOMIA	0.00555556	0.3635762054400714
FANCONI ANEMIA, COMPLEMENTATION GROUP R	0.00555556	0.3635762054400714
#260660 COUSIN SYNDROME;;CRANIOFACIAL DYSMORPHISM, HYPOPLASIA OF SCAPULA AND PELVIS, AND SHORTSTATURE;;PELVISCAPULAR DYSPLASIA	0.00555556	0.3635762054400714
#614195 CRANIOFACIAL ANOMALIES AND ANTERIOR SEGMENT DYSGENESIS SYNDROME; CAASDS	0.00555556	0.3635762054400714
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.00555556	0.3635762054400714
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.00555556	0.3635762054400714
DYSSEGMENTAL DYSPLASIA, ROLLAND-DESBUQUOIS TYPE	0.00555556	0.3635762054400714
#101200 APERT SYNDROME;;ACROCEPHALOSYNDACTYLY, TYPE I; ACS1;;ACS IAPERT-CROUZON DISEASE, INCLUDED;;ACROCEPHALOSYNDACTYLY, TYPE II, INCLUDED;;ACS II, INCLUDED;;VOGT CEPHALODACTYLY, INCLUDED	0.00555556	0.3635762054400714
#273395 TETRAAMELIA, AUTOSOMAL RECESSIVE	0.00555556	0.3635762054400714
#304120 OTOPALATODIGITAL SYNDROME, TYPE II; OPD2;;OPD II SYNDROME;;OPD SYNDROME 2;;CRANIOORODIGITAL SYNDROME;;FACIOPALATOOSSEOUS SYNDROME; FPO	0.00555556	0.3635762054400714
COLOBOMA-OBESITY-HYPOGENITALISM-MENTAL RETARDATION SYNDROME	0.00555556	0.3635762054400714
CAMPOMELIC DYSPLASIA	0.00555556	0.3635762054400714
#100800 ACHONDROPLASIA; ACH	0.00555556	0.3635762054400714
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.00555556	0.3635762054400714
DANDY-WALKER SYNDROME	0.00555556	0.3635762054400714
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.00555556	0.3635762054400714
BASAL CELL NEVUS SYNDROME	0.00555556	0.3635762054400714
VACTERL ASSOCIATION WITH HYDROCEPHALUS	0.00555556	0.3635762054400714
MECKEL SYNDROME, TYPE 6; MKS6	0.00555556	0.3635762054400714
CROUZON SYNDROME WITH ACANTHOSIS NIGRICANS	0.00555556	0.3635762054400714
RADIAL APLASIA, X-LINKED	0.00555556	0.3635762054400714
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.00555556	0.3635762054400714
HYDROCEPHALUS DUE TO CONGENITAL STENOSIS OF AQUEDUCT OF SYLVIUS	0.00555556	0.3635762054400714
#101600 PFEIFFER SYNDROME;;ACROCEPHALOSYNDACTYLY, TYPE V; ACS5;;ACS V;;NOACK SYNDROMECRANIOFACIAL-SKELETAL-DERMATOLOGIC DYSPLASIA, INCLUDED	0.00555556	0.3635762054400714
241800 HYPOTHALAMIC HAMARTOMASCONGENITAL HYPOTHALAMIC HAMARTOMA SYNDROME, INCLUDED; CHHS, INCLUDED	0.00555556	0.3635762054400714
236640 HYDROCEPHALUS WITH ASSOCIATED MALFORMATIONS	0.00555556	0.3635762054400714
BEEMER LETHAL MALFORMATION SYNDROME	0.00555556	0.3635762054400714
STROMME SYNDROME; STROMS	0.00555556	0.3635762054400714
KLEEBLATTSCHAEDEL SYNDROME	0.00555556	0.3635762054400714
THORACOABDOMINAL SYNDROME	0.00555556	0.3635762054400714
DANDY-WALKER MALFORMATION WITH MENTAL RETARDATION, MACROCEPHALY, MYOPIA, AND BRACHYTELEPHALANGY	0.00555556	0.3635762054400714
BIEMOND SYNDROME II	0.00555556	0.3635762054400714
243440 ISOTRETINOIN EMBRYOPATHY-LIKE SYNDROME;;MICROTIA-AORTIC ARCH SYNDROME	0.00555556	0.3635762054400714
COLE-CARPENTER SYNDROME 1; CLCRP1	0.00555556	0.3635762054400714
AASE-SMITH SYNDROME I	0.00555556	0.3635762054400714
TEMPLE SYNDROME	0.00555556	0.3635762054400714
307010 HYDROCEPHALUS WITH CEREBELLAR AGENESIS	0.00555556	0.3635762054400714
MYOPATHY, CENTRONUCLEAR, X-LINKED; CNMX	0.00555556	0.3635762054400714
HYDROCEPHALUS, TALL STATURE, JOINT LAXITY, AND KYPHOSCOLIOSIS	0.00555556	0.3635762054400714
Diamond-Blackfan anemia 1	0.00515464	0.3373385314189046
614262 ARTHROGRYPOSIS, PERTHES DISEASE, AND UPWARD GAZE PALSY; APUG	0.00515464	0.3373385314189046
Contractural arachnodactyly, congenital	0.00515464	0.3373385314189046
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.00515464	0.3373385314189046
ASPLENIA WITH CARDIOVASCULAR ANOMALIES	0.00515464	0.3373385314189046
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	0.00515464	0.3373385314189046
#150250 LARSEN SYNDROME; LRS	0.00515464	0.3373385314189046
DIAMOND-BLACKFAN ANEMIA 6; DBA6	0.00515464	0.3373385314189046
HETEROTAXY, VISCERAL, 7, AUTOSOMAL; HTX7	0.00515464	0.3373385314189046
DIAMOND-BLACKFAN ANEMIA 4	0.00515464	0.3373385314189046
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.00515464	0.3373385314189046
MESOAXIAL HEXADACTYLY AND CARDIAC MALFORMATION	0.00515464	0.3373385314189046
#208540 RENAL-HEPATIC-PANCREATIC DYSPLASIA; RHPD	0.00515464	0.3373385314189046
HETEROTAXY, VISCERAL, 1, X-LINKED; HTX1	0.00515464	0.3373385314189046
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.00515464	0.3373385314189046
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.00515464	0.3373385314189046
ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	0.00515464	0.3373385314189046
CARDIAC-UROGENITAL SYNDROME; CUGS	0.00515464	0.3373385314189046
NOONAN SYNDROME 8; NS8	0.00515464	0.3373385314189046
ALAGILLE SYNDROME 2	0.00515464	0.3373385314189046
ELLIS-VAN CREVELD SYNDROME	0.00515464	0.3373385314189046
WHITE FORELOCK WITH MALFORMATIONS	0.00515464	0.3373385314189046
#267010 MECKEL SYNDROME, TYPE 7; MKS7;;RENAL-HEPATIC-PANCREATIC DYSPLASIA WITH DANDY-WALKER CYST;;GOLDSTON SYNDROME	0.00515464	0.3373385314189046
SPONDYLOOCULAR SYNDROME; SOS	0.00515464	0.3373385314189046
#253300 SPINAL MUSCULAR ATROPHY, TYPE I; SMA1;;SMA I;;SMA, INFANTILE ACUTE FORM;;MUSCULAR ATROPHY, INFANTILE;;WERDNIG-HOFFMANN DISEASE	0.00515464	0.3373385314189046
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.00515464	0.3373385314189046
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.00515464	0.3373385314189046
LYMPHATIC MALFORMATION 7; LMPHM7	0.00515464	0.3373385314189046
#614432 VENTRICULAR SEPTAL DEFECT 3; VSD3	0.00515464	0.3373385314189046
%263630 POLYSYNDACTYLY WITH CARDIAC MALFORMATION;;BONNEAU SYNDROME	0.00515464	0.3373385314189046
%608572 BURN-MCKEOWN SYNDROME	0.00515464	0.3373385314189046
CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 3; CHTD3	0.00515464	0.3373385314189046
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.00515464	0.3373385314189046
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.00515464	0.3373385314189046
ATRIAL SEPTAL DEFECT 5	0.00515464	0.3373385314189046
PORENCEPHALY, CEREBELLAR HYPOPLASIA, AND INTERNAL MALFORMATIONS	0.00515464	0.3373385314189046
AORTIC VALVE DISEASE 3; AOVD3	0.00515464	0.3373385314189046
#602482 AXENFELD-RIEGER SYNDROME, TYPE 3; RIEG3;;AXENFELD-RIEGER ANOMALY WITH OR WITHOUT CARDIAC DEFECTS AND/OR SENSORINEURALHEARING LOSS;;ANTERIOR SEGMENT MESENCHYMAL DYSGENESIS;;ANTERIOR CHAMBER CLEAVAGE SYNDROME;;RIEGER SYNDROME, TYPE 3AXENFELD ANOMALY, INCLUDED;;RIEGER ANOMALY, INCLUDED;;AXENFELD-RIEGER ANOMALY, INCLUDED	0.00515464	0.3373385314189046
BRACHYDACTYLY, TYPE E, WITH ATRIAL SEPTAL DEFECT, TYPE II	0.00515464	0.3373385314189046
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.00515464	0.3373385314189046
%241310 HYPOMANDIBULAR FACIOCRANIAL DYSOSTOSIS	0.00515464	0.3373385314189046
8p23.1 deletion syndrome	0.00515464	0.3373385314189046
DIAMOND-BLACKFAN ANEMIA 16	0.00515464	0.3373385314189046
#163950 NOONAN SYNDROME 1; NS1;;NOONAN SYNDROME;;MALE TURNER SYNDROME;;FEMALE PSEUDO-TURNER SYNDROME;;TURNER PHENOTYPE WITH NORMAL KARYOTYPEPTERYGIUM COLLI SYNDROME, INCLUDED	0.00515464	0.3373385314189046
#607941 ATRIAL SEPTAL DEFECT 2; ASD2	0.00515464	0.3373385314189046
#614429 VENTRICULAR SEPTAL DEFECT 1; VSD1	0.00515464	0.3373385314189046
ALVEOLAR CAPILLARY DYSPLASIA WITH MISALIGNMENT OF PULMONARY VEINS; ACDMPV	0.00515464	0.3373385314189046
#614433 ATRIAL SEPTAL DEFECT 8; ASD8	0.00515464	0.3373385314189046
JOHANSON-BLIZZARD SYNDROME; JBS	0.00515464	0.3373385314189046
#270100 HETEROTAXY, VISCERAL, 5, AUTOSOMAL; HTX5;;SITUS INVERSUS VISCERUM; SIV	0.00515464	0.3373385314189046
DUANE-RADIAL RAY SYNDROME; DRRS	0.00515464	0.3373385314189046
CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 5; CHTD5	0.00515464	0.3373385314189046
EBSTEIN ANOMALY	0.00515464	0.3373385314189046
#614868 T-CELL IMMUNODEFICIENCY, RECURRENT INFECTIONS, AND AUTOIMMUNITY WITHOR WITHOUT CARDIAC MALFORMATIONS; TIIAC;;STK4 DEFICIENCY;;MST1 DEFICIENCY	0.00515464	0.3373385314189046
#613087 ATRIAL SEPTAL DEFECT 6; ASD6	0.00515464	0.3373385314189046
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.001759633	0.11515683191381772
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.001759633	0.11515683191381772
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.001759633	0.11515683191381772
KETOADIPICACIDURIA	0.001759633	0.11515683191381772
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.001759633	0.11515683191381772
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.001759633	0.11515683191381772
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.001759633	0.11515683191381772
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.001759633	0.11515683191381772
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.001759633	0.11515683191381772
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.001759633	0.11515683191381772
HARTNUP DISORDER	0.001759633	0.11515683191381772
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.001759633	0.11515683191381772
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.001759633	0.11515683191381772
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.001759633	0.11515683191381772
AICARDI-GOUTIERES SYNDROME 7	0.001759633	0.11515683191381772
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.001759633	0.11515683191381772
ADENYLOSUCCINASE DEFICIENCY	0.001759633	0.11515683191381772
CHROMOSOME 5Q12 DELETION SYNDROME	0.001759633	0.11515683191381772
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.001759633	0.11515683191381772
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.001759633	0.11515683191381772
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.001759633	0.11515683191381772
#225750 AICARDI-GOUTIERES SYNDROME 1; AGS1;;AGS;;ENCEPHALOPATHY, FAMILIAL INFANTILE, WITH INTRACRANIAL CALCIFICATIONAND CHRONIC CEREBROSPINAL FLUID LYMPHOCYTOSIS;;CREE ENCEPHALITIS;;PSEUDOTOXOPLASMOSIS SYNDROMEAICARDI-GOUTIERES SYNDROME 1, AUTOSOMAL DOMINANT, INCLUDED	0.001759633	0.11515683191381772
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.001759633	0.11515683191381772
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.001759633	0.11515683191381772
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.001759633	0.11515683191381772
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.001759633	0.11515683191381772
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.001759633	0.11515683191381772
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.001759633	0.11515683191381772
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.001759633	0.11515683191381772
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.001759633	0.11515683191381772
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.001759633	0.11515683191381772
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ix; CDG1X	0.001759633	0.11515683191381772
LISSENCEPHALY 8; LIS8	0.001759633	0.11515683191381772
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.001759633	0.11515683191381772
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.001759633	0.11515683191381772
CHROMOSOME 1p35 DELETION SYNDROME	0.001759633	0.11515683191381772
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.001759633	0.11515683191381772
Cerebral creatine deficiency syndrome 2	0.001759633	0.11515683191381772
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.001759633	0.11515683191381772
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.001759633	0.11515683191381772
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.001759633	0.11515683191381772
#245400 MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITHMETHYLMALONIC ACIDURIA); MTDPS9;;LACTIC ACIDOSIS, FATAL INFANTILE, FORMERLY	0.001759633	0.11515683191381772
#614322 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 12; SCAR12;;SPINOCEREBELLAR ATAXIA WITH MENTAL RETARDATION AND EPILEPSY	0.001759633	0.11515683191381772
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.001759633	0.11515683191381772
GM2-GANGLIOSIDOSIS, AB VARIANT	0.001759633	0.11515683191381772
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.001759633	0.11515683191381772
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.001759633	0.11515683191381772
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.001759633	0.11515683191381772
#311250 ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO;;ORNITHINE CARBAMOYLTRANSFERASE DEFICIENCY;;OTC DEFICIENCYVALPROATE SENSITIVITY, INCLUDED	0.001759633	0.11515683191381772
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.001759633	0.11515683191381772
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.001759633	0.11515683191381772
#615182 COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA; D2L2AD	0.001759633	0.11515683191381772
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.001759633	0.11515683191381772
RAYNAUD-CLAES SYNDROME; MRXSRC	0.001759633	0.11515683191381772
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia; CDG1A	0.001759633	0.11515683191381772
Pontine tegmental cap dysplasia	0.001759633	0.11515683191381772
#251290 BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA;BLCPMG;;PSEUDO-TORCH SYNDROME	0.001759633	0.11515683191381772
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.001759633	0.11515683191381772
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.001759633	0.11515683191381772
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.001759633	0.11515683191381772
LUSCAN-LUMISH SYNDROME; LLS	0.001759633	0.11515683191381772
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.001759633	0.11515683191381772
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.001759633	0.11515683191381772
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.001759633	0.11515683191381772
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.001759633	0.11515683191381772
#608027 PONTOCEREBELLAR HYPOPLASIA, TYPE 3; PCH3;;CEREBELLAR ATROPHY WITH PROGRESSIVE MICROCEPHALY; CLAM;;PCH WITH OPTIC ATROPHY	0.001759633	0.11515683191381772
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001759633	0.11515683191381772
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.001759633	0.11515683191381772
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.001759633	0.11515683191381772
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.001759633	0.11515683191381772
N-ACETYLASPARTATE DEFICIENCY; NACED	0.001759633	0.11515683191381772
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.001759633	0.11515683191381772
PHACE ASSOCIATION	0.001759633	0.11515683191381772
HOLOPROSENCEPHALY 1; HPE1	0.001759633	0.11515683191381772
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.001759633	0.11515683191381772
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.001759633	0.11515683191381772
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.001759633	0.11515683191381772
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.001759633	0.11515683191381772
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.001759633	0.11515683191381772
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.001759633	0.11515683191381772
#301835 ARTS SYNDROME; ARTS;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARTS TYPE; MRXSARTS;;ATAXIA, FATAL X-LINKED, WITH DEAFNESS AND LOSS OF VISION;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 18; MRXS18	0.001759633	0.11515683191381772
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.001759633	0.11515683191381772
CHROMOSOME 16p13.3 DELETION SYNDROME	0.001759633	0.11515683191381772
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.001759633	0.11515683191381772
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.001759633	0.11515683191381772
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.001759633	0.11515683191381772
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.001759633	0.11515683191381772
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.001759633	0.11515683191381772
#611718 HYPOMAGNESEMIA 4, RENAL; HOMG4;;HYPOMAGNESEMIA, RENAL, NORMOCALCIURIC	0.001759633	0.11515683191381772
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.001759633	0.11515683191381772
LISSENCEPHALY 4	0.001759633	0.11515683191381772
CHROMOSOME 16p13.2 DELETION SYNDROME	0.001759633	0.11515683191381772
TEMPLE-BARAITSER SYNDROME; TMBTS	0.001759633	0.11515683191381772
MENTAL RETARDATION, X-LINKED 103	0.001759633	0.11515683191381772
#614483 PORENCEPHALY 2; POREN2	0.001759633	0.11515683191381772
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.001759633	0.11515683191381772
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.001759633	0.11515683191381772
ZTTK SYNDROME; ZTTKS	0.001759633	0.11515683191381772
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.001759633	0.11515683191381772
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.001759633	0.11515683191381772
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.001759633	0.11515683191381772
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.001759633	0.11515683191381772
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.001759633	0.11515683191381772
#300422 FG SYNDROME 4; FGS4MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT NYSTAGMUS, INCLUDED	0.001759633	0.11515683191381772
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.001759633	0.11515683191381772
PELIZAEUS-MERZBACHER DISEASE	0.001759633	0.11515683191381772
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.001759633	0.11515683191381772
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.001759633	0.11515683191381772
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.001759633	0.11515683191381772
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.001759633	0.11515683191381772
#613668 MICROCEPHALY, POSTNATAL PROGRESSIVE, WITH SEIZURES AND BRAIN ATROPHY	0.001759633	0.11515683191381772
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.001759633	0.11515683191381772
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIq; CDG2Q	0.001759633	0.11515683191381772
MENTAL RETARDATION, X-LINKED 72	0.001759633	0.11515683191381772
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.001759633	0.11515683191381772
#613730 HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION,AND CATARACTS; HDBSCC	0.001759633	0.11515683191381772
#614845 NEPHRONOPHTHISIS 15; NPHP15	0.001759633	0.11515683191381772
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.001759633	0.11515683191381772
#604317 MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT CORTICALMALFORMATIONS; MCPH2	0.001759633	0.11515683191381772
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.001759633	0.11515683191381772
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.001759633	0.11515683191381772
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.001759633	0.11515683191381772
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.001759633	0.11515683191381772
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.001759633	0.11515683191381772
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.001759633	0.11515683191381772
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.001759633	0.11515683191381772
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.001759633	0.11515683191381772
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.001759633	0.11515683191381772
ARGININOSUCCINIC ACIDURIA	0.001759633	0.11515683191381772
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.001759633	0.11515683191381772
#612716 DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY;;SEPIAPTERIN REDUCTASE DEFICIENCY;;SPR DEFICIENCY	0.001759633	0.11515683191381772
ELEJALDE DISEASE	0.001759633	0.11515683191381772
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.001759633	0.11515683191381772
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.001759633	0.11515683191381772
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.001759633	0.11515683191381772
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.001759633	0.11515683191381772
#218000 AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY; ACCPN;;CHARLEVOIX DISEASE;;ANDERMANN SYNDROME;;POLYNEUROPATHY, SENSORIMOTOR, WITH OR WITHOUT AGENESIS OF THE CORPUSCALLOSUM;;CORPUS CALLOSUM, AGENESIS OF, WITH NEURONOPATHY	0.001759633	0.11515683191381772
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.001759633	0.11515683191381772
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.001759633	0.11515683191381772
CHROMOSOME 19q13.11 DELETION SYNDROME, PROXIMAL	0.001759633	0.11515683191381772
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.001759633	0.11515683191381772
POTOCKI-LUPSKI SYNDROME	0.001759633	0.11515683191381772
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.001759633	0.11515683191381772
#300673 ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATIONS	0.001759633	0.11515683191381772
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.001759633	0.11515683191381772
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.001759633	0.11515683191381772
MEHMO SYNDROME; MEHMO	0.001759633	0.11515683191381772
SALLA DISEASE	0.001759633	0.11515683191381772
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.001759633	0.11515683191381772
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.001759633	0.11515683191381772
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.001759633	0.11515683191381772
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.001759633	0.11515683191381772
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.001759633	0.11515683191381772
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.001759633	0.11515683191381772
COACH SYNDROME	0.001759633	0.11515683191381772
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.001759633	0.11515683191381772
CHROMOSOME 14q11-q22 DELETION SYNDROME	0.001759633	0.11515683191381772
NIEMANN-PICK DISEASE, TYPE C2	0.001759633	0.11515683191381772
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.001759633	0.11515683191381772
LANDAU-KLEFFNER SYNDROME	0.001759633	0.11515683191381772
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.001759633	0.11515683191381772
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.001759633	0.11515683191381772
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.001759633	0.11515683191381772
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.001759633	0.11515683191381772
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.001759633	0.11515683191381772
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.001759633	0.11515683191381772
GAUCHER DISEASE, TYPE II	0.001759633	0.11515683191381772
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.001759633	0.11515683191381772
SULFOCYSTEINURIA	0.001759633	0.11515683191381772
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.001759633	0.11515683191381772
JOUBERT SYNDROME 30; JBTS30	0.001759633	0.11515683191381772
GLASS SYNDROME	0.001759633	0.11515683191381772
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.001759633	0.11515683191381772
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.001759633	0.11515683191381772
#136570 CHROMOSOME 16p12.1 DELETION SYNDROME, 520-KBFRAGILE SITE 16p12, INCLUDED	0.001759633	0.11515683191381772
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.001759633	0.11515683191381772
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Il; CDG1L	0.001759633	0.11515683191381772
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iy; CDG1Y	0.001759633	0.11515683191381772
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.001759633	0.11515683191381772
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.001759633	0.11515683191381772
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.001759633	0.11515683191381772
ADAMS-OLIVER SYNDROME 2; AOS2	0.001759633	0.11515683191381772
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.001759633	0.11515683191381772
SHUKLA-VERNON SYNDROME; SHUVER	0.001759633	0.11515683191381772
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.001759633	0.11515683191381772
WAISMAN SYNDROME; WSMN	0.001759633	0.11515683191381772
METHYLMALONIC ACIDURIA, CBLA TYPE	0.001759633	0.11515683191381772
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik; CDG1K	0.001759633	0.11515683191381772
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.001759633	0.11515683191381772
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.001759633	0.11515683191381772
#207800 ARGININEMIA;;ARGINASE DEFICIENCY;;HYPERARGININEMIA;;ARG1 DEFICIENCY	0.001759633	0.11515683191381772
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij; CDG1J	0.001759633	0.11515683191381772
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.001759633	0.11515683191381772
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.001759633	0.11515683191381772
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.001759633	0.11515683191381772
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.001759633	0.11515683191381772
#226750 KOHLSCHUTTER-TONZ SYNDROME; KTZS;;EPILEPSY AND YELLOW TEETH;;EPILEPSY, DEMENTIA, AND AMELOGENESIS IMPERFECTA;;KOHLSCHUTTER SYNDROME	0.001759633	0.11515683191381772
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.001759633	0.11515683191381772
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.001759633	0.11515683191381772
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.001759633	0.11515683191381772
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.001759633	0.11515683191381772
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.001759633	0.11515683191381772
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.001759633	0.11515683191381772
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.001759633	0.11515683191381772
#300894 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5; NBIA5;;BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION; BPAN;;STATIC ENCEPHALOPATHY OF CHILDHOOD WITH NEURODEGENERATION IN ADULTHOOD;SENDA	0.001759633	0.11515683191381772
Pierpont syndrome	0.001759633	0.11515683191381772
VICI SYNDROME; VICIS	0.001759633	0.11515683191381772
#300653 PHOSPHOGLYCERATE KINASE 1 DEFICIENCY;;PGK1 DEFICIENCY	0.001759633	0.11515683191381772
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.001759633	0.11515683191381772
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.001759633	0.11515683191381772
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.001759633	0.11515683191381772
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.001759633	0.11515683191381772
#158350 COWDEN SYNDROME 1; CWS1;;CS; CD;;MULTIPLE HAMARTOMA SYNDROME; MHAMDYSPLASTIC GANGLIOCYTOMA OF THE CEREBELLUM, INCLUDED;;CEREBELLOPARENCHYMAL DISORDER VI, INCLUDED; CPD6, INCLUDED;;CEREBELLAR GRANULE CELL HYPERTROPHY AND MEGALENCEPHALY, INCLUDED;;LHERMITTE-DUCLOS DISEASE, INCLUDED; LDD, INCLUDED;;PROTEUS-LIKE SYNDROME, INCLUDED	0.001759633	0.11515683191381772
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.001759633	0.11515683191381772
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.001759633	0.11515683191381772
MENTAL RETARDATION, X-LINKED 91; MRX91	0.001759633	0.11515683191381772
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.001759633	0.11515683191381772
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.001759633	0.11515683191381772
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw; CDG1W	0.001759633	0.11515683191381772
GABA-TRANSAMINASE DEFICIENCY	0.001759633	0.11515683191381772
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.001759633	0.11515683191381772
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.001759633	0.11515683191381772
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.001759633	0.11515683191381772
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.001759633	0.11515683191381772
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.001759633	0.11515683191381772
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.001759633	0.11515683191381772
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic; CDG1C	0.001759633	0.11515683191381772
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.001759633	0.11515683191381772
TIMOTHY SYNDROME; TS	0.001759633	0.11515683191381772
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.001759633	0.11515683191381772
3-METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.001759633	0.11515683191381772
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.001759633	0.11515683191381772
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.001759633	0.11515683191381772
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.001759633	0.11515683191381772
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.001759633	0.11515683191381772
MENTAL RETARDATION, X-LINKED 9	0.001759633	0.11515683191381772
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.001759633	0.11515683191381772
#237300 CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY, HYPERAMMONEMIA DUE TO;;CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY;;CPS I DEFICIENCY	0.001759633	0.11515683191381772
PEHO SYNDROME; PEHO	0.001759633	0.11515683191381772
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.001759633	0.11515683191381772
#608804 LEUKODYSTROPHY, HYPOMYELINATING, 2; HLD2;;PELIZAEUS-MERZBACHER-LIKE DISEASE, 1; PMLD1	0.001759633	0.11515683191381772
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.001759633	0.11515683191381772
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.001759633	0.11515683191381772
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.001759633	0.11515683191381772
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.001759633	0.11515683191381772
#300845 MOYAMOYA DISEASE 4 WITH SHORT STATURE, HYPERGONADOTROPIC HYPOGONADISM,AND FACIAL DYSMORPHISM; MYMY4;;CHROMOSOME XQ28 DELETION SYNDROME, 3.4-KB;;SYNDROMIC MOYAMOYA DISEASE	0.001759633	0.11515683191381772
#269000 SC PHOCOMELIA SYNDROME;;SC PSEUDOTHALIDOMIDE SYNDROME	0.001759633	0.11515683191381772
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.001759633	0.11515683191381772
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.001759633	0.11515683191381772
#613657 D-2-@HYDROXYGLUTARIC ACIDURIA 2;;D2HGA2	0.001759633	0.11515683191381772
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.001759633	0.11515683191381772
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.001759633	0.11515683191381772
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001759633	0.11515683191381772
CITRULLINEMIA, CLASSIC	0.001759633	0.11515683191381772
CHROMOSOME 16p11.2 DELETION SYNDROME, 593-KB	0.001759633	0.11515683191381772
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIf; CDG2F	0.001759633	0.11515683191381772
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.001759633	0.11515683191381772
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.001759633	0.11515683191381772
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.001759633	0.11515683191381772
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001759633	0.11515683191381772
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.001759633	0.11515683191381772
MENTAL RETARDATION, X-LINKED 101; MRX101	0.001759633	0.11515683191381772
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.001759633	0.11515683191381772
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.001759633	0.11515683191381772
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id; CDG1D	0.001759633	0.11515683191381772
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.001759633	0.11515683191381772
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.001759633	0.11515683191381772
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.001759633	0.11515683191381772
#613744 SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE; SPG51;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 4, FORMERLY; CPSQ4, FORMERLY	0.001759633	0.11515683191381772
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.001759633	0.11515683191381772
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.001759633	0.11515683191381772
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.001759633	0.11515683191381772
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.001759633	0.11515683191381772
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.001759633	0.11515683191381772
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.001759633	0.11515683191381772
3-METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.001759633	0.11515683191381772
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.001759633	0.11515683191381772
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.001759633	0.11515683191381772
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.001759633	0.11515683191381772
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.001759633	0.11515683191381772
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.001759633	0.11515683191381772
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.001759633	0.11515683191381772
GLYCEROL KINASE DEFICIENCY; GKD	0.001759633	0.11515683191381772
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.001759633	0.11515683191381772
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.001759633	0.11515683191381772
#220120 D-GLYCERIC ACIDURIA;;D-GLYCERIC ACIDEMIA;;GLYCERATE KINASE DEFICIENCY	0.001759633	0.11515683191381772
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu; CDG1U	0.001759633	0.11515683191381772
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.001759633	0.11515683191381772
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.001759633	0.11515683191381772
#612936 SPASTIC PARAPLEGIA 50, AUTOSOMAL RECESSIVE; SPG50;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3, FORMERLY; CPSQ3, FORMERLY	0.001759633	0.11515683191381772
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.001759633	0.11515683191381772
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.001759633	0.11515683191381772
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.001759633	0.11515683191381772
#243500 ISOVALERIC ACIDEMIA; IVA;;ISOVALERIC ACID CoA DEHYDROGENASE DEFICIENCY;;IVD DEFICIENCY	0.001759633	0.11515683191381772
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.001759633	0.11515683191381772
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.001759633	0.11515683191381772
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.001759633	0.11515683191381772
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.001759633	0.11515683191381772
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.001759633	0.11515683191381772
PYRUVATE CARBOXYLASE DEFICIENCY	0.001759633	0.11515683191381772
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.001759633	0.11515683191381772
SCHINDLER DISEASE, TYPE I	0.001759633	0.11515683191381772
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001759633	0.11515683191381772
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.001759633	0.11515683191381772
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.001759633	0.11515683191381772
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.001759633	0.11515683191381772
2,4-DIENOYL-CoA REDUCTASE DEFICIENCY; DECRD	0.001759633	0.11515683191381772
Muenke syndrome	0.001759633	0.11515683191381772
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.001759633	0.11515683191381772
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip; CDG1P	0.001759633	0.11515683191381772
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001759633	0.11515683191381772
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.001759633	0.11515683191381772
MENTAL RETARDATION, X-LINKED 88	0.001759633	0.11515683191381772
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.001759633	0.11515683191381772
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.001759633	0.11515683191381772
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.001759633	0.11515683191381772
MENTAL RETARDATION, X-LINKED 104; MRX104	0.001759633	0.11515683191381772
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.001759633	0.11515683191381772
GRISCELLI SYNDROME, TYPE 1	0.001759633	0.11515683191381772
WEBB-DATTANI SYNDROME; WEDAS	0.001759633	0.11515683191381772
LEIGH SYNDROME; LS	0.001759633	0.11515683191381772
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.001759633	0.11515683191381772
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.001759633	0.11515683191381772
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.001759633	0.11515683191381772
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.001759633	0.11515683191381772
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.001759633	0.11515683191381772
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.001759633	0.11515683191381772
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.001759633	0.11515683191381772
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.001759633	0.11515683191381772
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.001759633	0.11515683191381772
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.001759633	0.11515683191381772
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.001759633	0.11515683191381772
PALLISTER-HALL SYNDROME	0.001759633	0.11515683191381772
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.001759633	0.11515683191381772
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.001759633	0.11515683191381772
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.001759633	0.11515683191381772
#613180 POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.001759633	0.11515683191381772
#606777 GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1;;GLUCOSE TRANSPORT DEFECT, BLOOD-BRAIN BARRIERGLUT1 DEFICIENCY SYNDROME 1, AUTOSOMAL RECESSIVE, INCLUDED	0.001759633	0.11515683191381772
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.001759633	0.11515683191381772
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.001759633	0.11515683191381772
FOLATE MALABSORPTION, HEREDITARY	0.001759633	0.11515683191381772
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.001759633	0.11515683191381772
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001759633	0.11515683191381772
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.001759633	0.11515683191381772
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.001759633	0.11515683191381772
#615279 CARDIOFACIOCUTANEOUS SYNDROME 3; CFC3	0.001759633	0.11515683191381772
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.001759633	0.11515683191381772
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.001759633	0.11515683191381772
INFANTILE LIVER FAILURE SYNDROME 1	0.001759633	0.11515683191381772
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.001759633	0.11515683191381772
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.001759633	0.11515683191381772
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.001759633	0.11515683191381772
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl; CDG2L	0.001759633	0.11515683191381772
#235400 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1; AHUS1;;AHUS, SUSCEPTIBILITY TO, 1HEMOLYTIC UREMIC SYNDROME, TYPICAL, INCLUDED	0.000915751	0.05993010132335009
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.000915751	0.05993010132335009
#222300 WOLFRAM SYNDROME 1; WFS1;;WFS;;DIABETES INSIPIDUS AND MELLITUS WITH OPTIC ATROPHY AND DEAFNESS; DIDMOAD	0.000915751	0.05993010132335009
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.000915751	0.05993010132335009
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.000915751	0.05993010132335009
#200150 CHOREOACANTHOCYTOSIS; CHAC;;LEVINE-CRITCHLEY SYNDROME;;ACANTHOCYTOSIS WITH NEUROLOGIC DISORDER;;NEUROACANTHOCYTOSIS;;CHOREA-ACANTHOCYTOSIS	0.000915751	0.05993010132335009
#520000 DIABETES AND DEAFNESS, MATERNALLY INHERITED; MIDD;;DIABETES-DEAFNESS SYNDROME, MATERNALLY TRANSMITTED;;BALLINGER-WALLACE SYNDROME;;DIABETES MELLITUS, TYPE II, WITH DEAFNESS;;NONINSULIN-DEPENDENT DIABETES MELLITUS WITH DEAFNESS;;NIDDM WITH DEAFNESS	0.000915751	0.05993010132335009
#256731 CEROID LIPOFUSCINOSIS, NEURONAL, 5; CLN5;;CEROID LIPOFUSCINOSIS, NEURONAL, 5, VARIABLE AGE AT ONSETNEURONAL CEROID LIPOFUSCINOSIS, LATE INFANTILE, FINNISH VARIANT, INCLUDED;;FINNISH vLINCL, INCLUDED	0.000915751	0.05993010132335009
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.000915751	0.05993010132335009
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.000915751	0.05993010132335009
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.000915751	0.05993010132335009
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.000915751	0.05993010132335009
#608836 CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, ANTENATAL;;CPT II DEFICIENCY, LETHAL NEONATAL;;CPT2 DEFICIENCY, LETHAL NEONATAL	0.000915751	0.05993010132335009
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000915751	0.05993010132335009
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, cblX TYPE	0.000915751	0.05993010132335009
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000915751	0.05993010132335009
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.000915751	0.05993010132335009
MENTAL RETARDATION, X-LINKED 82	0.000915751	0.05993010132335009
#119540 CLEFT PALATE, ISOLATED; CPI;;CLEFT PALATE; CPCLEFT PALATE, ISOLATED, AND MENTAL RETARDATION, INCLUDED	0.000915751	0.05993010132335009
KIFAFA SEIZURE DISORDER	0.000915751	0.05993010132335009
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000915751	0.05993010132335009
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000915751	0.05993010132335009
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000915751	0.05993010132335009
CEREBELLOPARENCHYMAL DISORDER II	0.000915751	0.05993010132335009
EPILEPSY, BENIGN OCCIPITAL	0.000915751	0.05993010132335009
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000915751	0.05993010132335009
#202200 GLUCOCORTICOID DEFICIENCY 1; GCCD1;;FAMILIAL GLUCOCORTICOID DEFICIENCY 1; FGD1;;ADRENAL UNRESPONSIVENESS TO ACTH;;ACTH RESISTANCE	0.000915751	0.05993010132335009
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.000915751	0.05993010132335009
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.000915751	0.05993010132335009
224250 DYSMYELINATION WITH JAUNDICE	0.000915751	0.05993010132335009
#187300 TELANGIECTASIA, HEREDITARY HEMORRHAGIC, OF RENDU, OSLER, AND WEBER;HHT;;OSLER-RENDU-WEBER DISEASE;;ORW DISEASETELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 1, INCLUDED; HHT1, INCLUDED	0.000915751	0.05993010132335009
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.000915751	0.05993010132335009
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000915751	0.05993010132335009
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.000915751	0.05993010132335009
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.000915751	0.05993010132335009
KNOBLOCH SYNDROME 1; KNO1	0.000915751	0.05993010132335009
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000915751	0.05993010132335009
MENTAL RETARDATION, X-LINKED 100	0.000915751	0.05993010132335009
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000915751	0.05993010132335009
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.000915751	0.05993010132335009
MARDEN-WALKER SYNDROME	0.000915751	0.05993010132335009
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000915751	0.05993010132335009
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.000915751	0.05993010132335009
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.000915751	0.05993010132335009
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000915751	0.05993010132335009
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000915751	0.05993010132335009
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000915751	0.05993010132335009
#613707 LEOPARD SYNDROME 3; LPRD3	0.000915751	0.05993010132335009
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000915751	0.05993010132335009
HYPER-BETA-ALANINEMIA	0.000915751	0.05993010132335009
#177980 PTERYGIA, MENTAL RETARDATION, AND DISTINCTIVE CRANIOFACIAL FEATURES;;HASPESLAGH SYNDROME	0.000915751	0.05993010132335009
FRAGILE X MENTAL RETARDATION SYNDROME	0.000915751	0.05993010132335009
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.000915751	0.05993010132335009
OCULOCEREBROCUTANEOUS SYNDROME	0.000915751	0.05993010132335009
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000915751	0.05993010132335009
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.000915751	0.05993010132335009
VISCERAL STEATOSIS, CONGENITAL	0.000915751	0.05993010132335009
PERRAULT SYNDROME 3	0.000915751	0.05993010132335009
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.000915751	0.05993010132335009
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.000915751	0.05993010132335009
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000915751	0.05993010132335009
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.000915751	0.05993010132335009
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.000915751	0.05993010132335009
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.000915751	0.05993010132335009
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.000915751	0.05993010132335009
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000915751	0.05993010132335009
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.000915751	0.05993010132335009
DIAMINOPENTANURIA	0.000915751	0.05993010132335009
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.000915751	0.05993010132335009
THREONINEMIA	0.000915751	0.05993010132335009
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.000915751	0.05993010132335009
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.000915751	0.05993010132335009
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000915751	0.05993010132335009
FLYNN-AIRD SYNDROME	0.000915751	0.05993010132335009
MAPLE SYRUP URINE DISEASE; MSUD	0.000915751	0.05993010132335009
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.000915751	0.05993010132335009
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.000915751	0.05993010132335009
WARBURG MICRO SYNDROME 3; WARBM3	0.000915751	0.05993010132335009
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.000915751	0.05993010132335009
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000915751	0.05993010132335009
#141500 MIGRAINE, FAMILIAL HEMIPLEGIC, 1; FHM1;;FHM;;MHP1MIGRAINE, FAMILIAL HEMIPLEGIC 1, WITH PROGRESSIVE CEREBELLAR ATAXIA,INCLUDED;;MIGRAINE, SPORADIC HEMIPLEGIC, INCLUDED	0.000915751	0.05993010132335009
HHHH SYNDROME	0.000915751	0.05993010132335009
#612199 CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS; CRMCC;;COATS PLUS SYNDROME	0.000915751	0.05993010132335009
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000915751	0.05993010132335009
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.000915751	0.05993010132335009
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.000915751	0.05993010132335009
ICHTHYOSIS AND MALE HYPOGONADISM	0.000915751	0.05993010132335009
#612462 PSEUDOHYPOPARATHYROIDISM, TYPE IC; PHP1C;;PHP IC	0.000915751	0.05993010132335009
#602541 MUSCULAR DYSTROPHY, CONGENITAL, MEGACONIAL TYPE; MDCMC;;MUSCULAR DYSTROPHY, CONGENITAL, WITH MITOCHONDRIAL STRUCTURAL ABNORMALITIES	0.000915751	0.05993010132335009
PERRAULT SYNDROME 5; PRLTS5	0.000915751	0.05993010132335009
HYPOMAGNESEMIA 2, RENAL	0.000915751	0.05993010132335009
PSEUDO-TORCH SYNDROME 2	0.000915751	0.05993010132335009
ATKIN-FLAITZ SYNDROME	0.000915751	0.05993010132335009
ASPARTYLGLUCOSAMINURIA; AGU	0.000915751	0.05993010132335009
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.000915751	0.05993010132335009
NEUROFIBROMATOSIS, TYPE II	0.000915751	0.05993010132335009
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000915751	0.05993010132335009
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000915751	0.05993010132335009
COWDEN SYNDROME 6; CWS6	0.000915751	0.05993010132335009
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000915751	0.05993010132335009
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.000915751	0.05993010132335009
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.000915751	0.05993010132335009
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.000915751	0.05993010132335009
SECKEL SYNDROME 7; SCKL7	0.000915751	0.05993010132335009
AUTISM	0.000915751	0.05993010132335009
CRANIOSYNOSTOSIS 2	0.000915751	0.05993010132335009
ACTH DEFICIENCY, ISOLATED; IAD	0.000915751	0.05993010132335009
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.000915751	0.05993010132335009
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.000915751	0.05993010132335009
#158900 FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1; FSHD1;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1;;FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FSHD; FMD;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1A; FSHD1A;;LANDOUZY-DEJERINE MUSCULAR DYSTROPHYFACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY, INFANTILE, INCLUDED;;FACIOSCAPULOHUMERAL DYSTROPHY WITH SENSORINEURAL HEARING LOSS ANDTORTUOSITY OF RETINAL ARTERIOLES, INCLUDED	0.000915751	0.05993010132335009
INCONTINENTIA PIGMENTI; IP	0.000915751	0.05993010132335009
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.000915751	0.05993010132335009
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.000915751	0.05993010132335009
#229600 FRUCTOSE INTOLERANCE, HEREDITARY;;FRUCTOSEMIA;;FRUCTOSE-1-PHOSPHATE ALDOLASE DEFICIENCY;;FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE B DEFICIENCY;;ALDOLASE B DEFICIENCY;;ALDOB DEFICIENCY	0.000915751	0.05993010132335009
XYLOSIDASE DEFICIENCY	0.000915751	0.05993010132335009
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.000915751	0.05993010132335009
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.000915751	0.05993010132335009
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.000915751	0.05993010132335009
MICROPHTHALMIA, SYNDROMIC 1	0.000915751	0.05993010132335009
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.000915751	0.05993010132335009
HYPOPARATHYROIDISM, X-LINKED	0.000915751	0.05993010132335009
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000915751	0.05993010132335009
#614923 BRANCHED-CHAIN KETOACID DEHYDROGENASE KINASE DEFICIENCY; BCKDKD;;BCKDK DEFICIENCY	0.000915751	0.05993010132335009
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.000915751	0.05993010132335009
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.000915751	0.05993010132335009
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.000915751	0.05993010132335009
MENTAL RETARDATION, X-LINKED 1	0.000915751	0.05993010132335009
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.000915751	0.05993010132335009
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.000915751	0.05993010132335009
SUDDEN CARDIAC FAILURE, INFANTILE	0.000915751	0.05993010132335009
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.000915751	0.05993010132335009
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.000915751	0.05993010132335009
GLYCINE ENCEPHALOPATHY; GCE	0.000915751	0.05993010132335009
#615705 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 15; SCAR15;;SALIH ATAXIA	0.000915751	0.05993010132335009
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.000915751	0.05993010132335009
SECKEL SYNDROME 1; SCKL1	0.000915751	0.05993010132335009
INFANTILE LIVER FAILURE SYNDROME 2	0.000915751	0.05993010132335009
GLUTAMINE DEFICIENCY, CONGENITAL	0.000915751	0.05993010132335009
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000915751	0.05993010132335009
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000915751	0.05993010132335009
DYSOSTEOSCLEROSIS	0.000915751	0.05993010132335009
#615663 WARBURG MICRO SYNDROME 4; WARBM4	0.000915751	0.05993010132335009
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.000915751	0.05993010132335009
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.000915751	0.05993010132335009
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.000915751	0.05993010132335009
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000915751	0.05993010132335009
#300049 HETEROTOPIA, PERIVENTRICULAR, X-LINKED DOMINANT;;HETEROTOPIA, FAMILIAL NODULAR;;PERIVENTRICULAR NODULAR HETEROTOPIA 1; PVNH1;;NODULAR HETEROTOPIA, BILATERAL PERIVENTRICULAR; NHBP; BPNHHETEROTOPIA, PERIVENTRICULAR NODULAR, WITH FRONTOMETAPHYSEAL DYSPLASIA,INCLUDED	0.000915751	0.05993010132335009
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.000915751	0.05993010132335009
#612951 LEUKOENCEPHALOPATHY, CYSTIC, WITHOUT MEGALENCEPHALY	0.000915751	0.05993010132335009
#248250 HYPOMAGNESEMIA 3, RENAL; HOMG3;;HYPOMAGNESEMIA, PRIMARY, DUE TO DEFECT IN RENAL TUBULAR TRANSPORTOF MAGNESIUM;;HYPOMAGNESEMIA, ISOLATED RENAL;;HYPOMAGNESEMIA, FAMILIAL, WITH HYPERCALCIURIA AND NEPHROCALCINOSISHYPERCALCIURIA, CHILDHOOD, SELF-LIMITING, INCLUDED	0.000915751	0.05993010132335009
MENTAL RETARDATION, X-LINKED 14	0.000915751	0.05993010132335009
PREECLAMPSIA/ECLAMPSIA 1	0.000915751	0.05993010132335009
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000915751	0.05993010132335009
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.000915751	0.05993010132335009
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.000915751	0.05993010132335009
#309510 PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME; PRTS;;PARTINGTON SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 1; MRXS1;;MENTAL RETARDATION, X-LINKED, WITH DYSTONIC MOVEMENTS, ATAXIA, ANDSEIZURES;;MENTAL RETARDATION, X-LINKED 36; MRX36	0.000915751	0.05993010132335009
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.000915751	0.05993010132335009
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000915751	0.05993010132335009
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.000915751	0.05993010132335009
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.000915751	0.05993010132335009
#264470 PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY;;STRAIGHT-CHAIN ACYL-CoA OXIDASE DEFICIENCY;;PSEUDONEONATAL ADRENOLEUKODYSTROPHY	0.000915751	0.05993010132335009
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIj; CDG2J	0.000915751	0.05993010132335009
#604004 MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 1; MLC1;;VACUOLATING MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS;;LVM;;VL;;LEUKOENCEPHALOPATHY WITH SWELLING AND CYSTS;;VAN DER KNAAP DISEASE	0.000915751	0.05993010132335009
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.000915751	0.05993010132335009
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.000915751	0.05993010132335009
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.000915751	0.05993010132335009
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000915751	0.05993010132335009
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.000915751	0.05993010132335009
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.000915751	0.05993010132335009
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.000915751	0.05993010132335009
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.000915751	0.05993010132335009
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000915751	0.05993010132335009
KEUTEL SYNDROME; KTLS	0.000915751	0.05993010132335009
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.000915751	0.05993010132335009
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.000915751	0.05993010132335009
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.000915751	0.05993010132335009
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.000915751	0.05993010132335009
CHROMOSOME 15q11-q13 DUPLICATION SYNDROME	0.000915751	0.05993010132335009
PARIETAL FORAMINA	0.000915751	0.05993010132335009
Wolf-Hirschhorn Syndrome	0.000915751	0.05993010132335009
EPISODIC ATAXIA, TYPE 6	0.000915751	0.05993010132335009
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.000915751	0.05993010132335009
#116860 CEREBRAL CAVERNOUS MALFORMATIONS; CCM;;CAVERNOUS ANGIOMA, FAMILIAL;;CAVERNOUS ANGIOMATOUS MALFORMATIONS; CAM;;CEREBRAL CAPILLARY MALFORMATIONSCEREBRAL CAVERNOUS MALFORMATIONS 1, INCLUDED; CCM1, INCLUDED;;CAVERNOUS MALFORMATIONS OF CNS AND RETINA, INCLUDED;;HYPERKERATOTIC CUTANEOUS CAPILLARY-VENOUS MALFORMATIONS ASSOCIATEDWITH CEREBRAL CAPILLARY MALFORMATIONS, INCLUDED	0.000915751	0.05993010132335009
#614399 MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET;EMARDDMYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET,MILD VARIANT, INCLUDED	0.000915751	0.05993010132335009
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.000915751	0.05993010132335009
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000915751	0.05993010132335009
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000915751	0.05993010132335009
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.000915751	0.05993010132335009
#300558 MENTAL RETARDATION, X-LINKED 30; MRX30;;MENTAL RETARDATION, X-LINKED 47; MRX47	0.000915751	0.05993010132335009
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000915751	0.05993010132335009
#612285 JOUBERT SYNDROME 9; JBTS9JOUBERT SYNDROME 9/15, DIGENIC, INCLUDED	0.000915751	0.05993010132335009
#609060 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1; COXPD1;;HEPATOENCEPHALOPATHY, EARLY FATAL PROGRESSIVE	0.000915751	0.05993010132335009
GURRIERI SYNDROME	0.000915751	0.05993010132335009
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000915751	0.05993010132335009
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.000915751	0.05993010132335009
PHENYLKETONURIA	0.000915751	0.05993010132335009
2q33.1 deletion syndrome	0.000915751	0.05993010132335009
#240900 HYPOINSULINEMIC HYPOGLYCEMIA WITH HEMIHYPERTROPHY; HIHGHH	0.000915751	0.05993010132335009
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.000915751	0.05993010132335009
#300337 HYPOMELANOSIS OF ITO; HMI;;INCONTINENTIA PIGMENTI ACHROMIANS; IPA;;ITO HYPOMELANOSIS; ITO;;INCONTINENTIA PIGMENTI, TYPE I, FORMERLY; IP1, FORMERLY	0.000915751	0.05993010132335009
COWDEN SYNDROME 5; CWS5	0.000915751	0.05993010132335009
EPILEPSY, READING	0.000915751	0.05993010132335009
SPINOCEREBELLAR ATAXIA 47; SCA47	0.000915751	0.05993010132335009
#300607 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 8; EIEE8;;HYPEREKPLEXIA AND EPILEPSY	0.000915751	0.05993010132335009
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.000915751	0.05993010132335009
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.000915751	0.05993010132335009
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.000915751	0.05993010132335009
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.000915751	0.05993010132335009
RETINITIS PIGMENTOSA 59; RP59	0.000915751	0.05993010132335009
#610539 GAUCHER DISEASE, ATYPICAL, DUE TO SAPOSIN C DEFICIENCY	0.000915751	0.05993010132335009
LISSENCEPHALY 3; LIS3	0.000915751	0.05993010132335009
GAUCHER DISEASE, PERINATAL LETHAL	0.000915751	0.05993010132335009
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.000915751	0.05993010132335009
#612475 CHROMOSOME 1q21.1 DUPLICATION SYNDROME	0.000915751	0.05993010132335009
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.000915751	0.05993010132335009
HYPERPROLINEMIA, TYPE II	0.000915751	0.05993010132335009
MENTAL RETARDATION, FRA12A TYPE	0.000915751	0.05993010132335009
Fabry disease	0.000915751	0.05993010132335009
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000915751	0.05993010132335009
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000915751	0.05993010132335009
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.000915751	0.05993010132335009
HYPOADRENOCORTICISM, FAMILIAL	0.000915751	0.05993010132335009
Angelman syndrome (Type 2)	0.000915751	0.05993010132335009
LISSENCEPHALY, X-LINKED, 2	0.000915751	0.05993010132335009
#603285 CEREBRAL CAVERNOUS MALFORMATIONS 3; CCM3	0.000915751	0.05993010132335009
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000915751	0.05993010132335009
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.000915751	0.05993010132335009
#236792 L-2-HYDROXYGLUTARIC ACIDURIA;;L-2-HYDROXYGLUTARIC ACIDEMIA	0.000915751	0.05993010132335009
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.000915751	0.05993010132335009
#605375 EPILEPSY, NOCTURNAL FRONTAL LOBE, 3; ENFL3	0.000915751	0.05993010132335009
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000915751	0.05993010132335009
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000915751	0.05993010132335009
STURGE-WEBER SYNDROME	0.000915751	0.05993010132335009
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.000915751	0.05993010132335009
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.000915751	0.05993010132335009
#276710 TYROSINEMIA, TYPE III; TYRSN3;;4-@HYDROXYPHENYLPYRUVIC ACID OXIDASE DEFICIENCY;;4-@HYDROXYPHENYLPYRUVATE DIOXYGENASE DEFICIENCY	0.000915751	0.05993010132335009
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.000915751	0.05993010132335009
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.000915751	0.05993010132335009
IMMUNODEFICIENCY 47	0.000915751	0.05993010132335009
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.000915751	0.05993010132335009
#614650 COENZYME Q10 DEFICIENCY, PRIMARY, 6; COQ10D6	0.000915751	0.05993010132335009
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000915751	0.05993010132335009
#612580 MENTAL RETARDATION, AUTOSOMAL DOMINANT 3; MRD3	0.000915751	0.05993010132335009
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000915751	0.05993010132335009
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.000915751	0.05993010132335009
CROME SYNDROME	0.000915751	0.05993010132335009
CYCLIC VOMITING SYNDROME	0.000915751	0.05993010132335009
NEURAMINIDASE DEFICIENCY	0.000915751	0.05993010132335009
HYPERLEUCINE-ISOLEUCINEMIA	0.000915751	0.05993010132335009
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.000915751	0.05993010132335009
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.000915751	0.05993010132335009
THYROCEREBRORETINAL SYNDROME	0.000915751	0.05993010132335009
GLUTATHIONE SYNTHETASE DEFICIENCY	0.000915751	0.05993010132335009
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.000915751	0.05993010132335009
#310600 NORRIE DISEASE; ND;;ATROPHIA BULBORUM HEREDITARIA;;EPISKOPI BLINDNESS	0.000915751	0.05993010132335009
#615752 POLYMICROGYRIA, BILATERAL PERISYLVIAN, AUTOSOMAL RECESSIVE; BPPR ;;PMGR	0.000915751	0.05993010132335009
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000915751	0.05993010132335009
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.000915751	0.05993010132335009
ZUNICH NEUROECTODERMAL SYNDROME	0.000915751	0.05993010132335009
#223360 DOPAMINE BETA-HYDROXYLASE DEFICIENCY, CONGENITAL;;NOREPINEPHRINE DEFICIENCY;;NORADRENALINE DEFICIENCY	0.000915751	0.05993010132335009
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.000915751	0.05993010132335009
KEARNS-SAYRE SYNDROME; KSS	0.000915751	0.05993010132335009
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.000915751	0.05993010132335009
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.000915751	0.05993010132335009
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.000915751	0.05993010132335009
#103580 PSEUDOHYPOPARATHYROIDISM, TYPE IA; PHP1A;;PHP IA;;ALBRIGHT HEREDITARY OSTEODYSTROPHY WITH MULTIPLE HORMONE RESISTANCE	0.000915751	0.05993010132335009
FOUNTAIN SYNDROME	0.000915751	0.05993010132335009
HUNTINGTON DISEASE; HD	0.000915751	0.05993010132335009
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.000915751	0.05993010132335009
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.000915751	0.05993010132335009
SJOGREN-LARSSON SYNDROME; SLS	0.000915751	0.05993010132335009
#244460 KENNY-CAFFEY SYNDROME, TYPE 1; KCS1;;KCS;;KENNY-CAFFEY SYNDROME, AUTOSOMAL RECESSIVE	0.000915751	0.05993010132335009
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000915751	0.05993010132335009
PAPILLORENAL SYNDROME	0.000915751	0.05993010132335009
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000915751	0.05993010132335009
DARIER-WHITE DISEASE; DAR	0.000915751	0.05993010132335009
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.000915751	0.05993010132335009
HYPOPHOSPHATASIA, CHILDHOOD	0.000915751	0.05993010132335009
SNEDDON SYNDROME	0.000915751	0.05993010132335009
MENTAL RETARDATION, X-LINKED 102	0.000915751	0.05993010132335009
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.000915751	0.05993010132335009
GRISCELLI SYNDROME, TYPE 2; GS2	0.000915751	0.05993010132335009
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.000915751	0.05993010132335009
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.000915751	0.05993010132335009
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000915751	0.05993010132335009
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000915751	0.05993010132335009
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.000915751	0.05993010132335009
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.000915751	0.05993010132335009
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.000915751	0.05993010132335009
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.000915751	0.05993010132335009
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000915751	0.05993010132335009
Angelman syndrome (Type 1)	0.000915751	0.05993010132335009
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000915751	0.05993010132335009
IMMUNODEFICIENCY 37; IMD37	0.000915751	0.05993010132335009
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.000915751	0.05993010132335009
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000915751	0.05993010132335009
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.000915751	0.05993010132335009
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.000915751	0.05993010132335009
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.000915751	0.05993010132335009
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000915751	0.05993010132335009
TAY-SACHS DISEASE; TSD	0.000915751	0.05993010132335009
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.000915751	0.05993010132335009
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.000915751	0.05993010132335009
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.000915751	0.05993010132335009
CLARK-BARAITSER SYNDROME	0.000915751	0.05993010132335009
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.000915751	0.05993010132335009
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.000915751	0.05993010132335009
COPPER DEFICIENCY, FAMILIAL BENIGN	0.000915751	0.05993010132335009
1p36 microdeletion syndrome	0.000915751	0.05993010132335009
RAMON SYNDROME	0.000915751	0.05993010132335009
HYPERLYSINEMIA, TYPE I	0.000915751	0.05993010132335009
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.000915751	0.05993010132335009
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.000915751	0.05993010132335009
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.000915751	0.05993010132335009
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000915751	0.05993010132335009
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.000915751	0.05993010132335009
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000915751	0.05993010132335009
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.000915751	0.05993010132335009
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.000915751	0.05993010132335009
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.000915751	0.05993010132335009
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.000915751	0.05993010132335009
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.000915751	0.05993010132335009
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.000915751	0.05993010132335009
GLUTARIC ACIDEMIA I; GA1	0.000915751	0.05993010132335009
PACHYGYRIA, FRONTOTEMPORAL	0.000915751	0.05993010132335009
RETINAL DEGENERATION AND EPILEPSY	0.000915751	0.05993010132335009
LATHOSTEROLOSIS	0.000915751	0.05993010132335009
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.000915751	0.05993010132335009
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.000915751	0.05993010132335009
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.000915751	0.05993010132335009
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000915751	0.05993010132335009
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.000915751	0.05993010132335009
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.000915751	0.05993010132335009
LISSENCEPHALY, X-LINKED, 1; LISX1	0.000915751	0.05993010132335009
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.000915751	0.05993010132335009
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.000915751	0.05993010132335009
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000915751	0.05993010132335009
#608033 ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3; IIAE3;;ENCEPHALOPATHY, ACUTE NECROTIZING, SUSCEPTIBILITY TO; ANE	0.000915751	0.05993010132335009
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.000915751	0.05993010132335009
MECKEL SYNDROME, TYPE 10; MKS10	0.000915751	0.05993010132335009
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.000915751	0.05993010132335009
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.000915751	0.05993010132335009
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000915751	0.05993010132335009
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.000915751	0.05993010132335009
311450 PALLISTER W SYNDROME;;W SYNDROME	0.000915751	0.05993010132335009
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.000915751	0.05993010132335009
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000915751	0.05993010132335009
SUPRABULBAR PARESIS, CONGENITAL	0.000915751	0.05993010132335009
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000915751	0.05993010132335009
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000843882	0.05522673059046762
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000843882	0.05522673059046762
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.000843882	0.05522673059046762
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.000843882	0.05522673059046762
MENTAL RETARDATION, X-LINKED 99	0.000843882	0.05522673059046762
SEPTOOPTIC DYSPLASIA	0.000843882	0.05522673059046762
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.000843882	0.05522673059046762
#614402 MICROPHTHALMIA, SYNDROMIC 11; MCOPS11	0.000843882	0.05522673059046762
Cerebral creatine deficiency syndrome 3	0.000843882	0.05522673059046762
BARDET-BIEDL SYNDROME 14; BBS14	0.000843882	0.05522673059046762
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000843882	0.05522673059046762
JOUBERT SYNDROME 27	0.000843882	0.05522673059046762
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.000843882	0.05522673059046762
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000843882	0.05522673059046762
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.000843882	0.05522673059046762
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000843882	0.05522673059046762
#604804 MICROCEPHALY 3, PRIMARY, AUTOSOMAL RECESSIVE; MCPH3	0.000843882	0.05522673059046762
LIG4 SYNDROME	0.000843882	0.05522673059046762
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.000843882	0.05522673059046762
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000843882	0.05522673059046762
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.000843882	0.05522673059046762
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000843882	0.05522673059046762
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.000843882	0.05522673059046762
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000843882	0.05522673059046762
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 1; CEMCOX1	0.000843882	0.05522673059046762
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.000843882	0.05522673059046762
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.000843882	0.05522673059046762
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000843882	0.05522673059046762
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.000843882	0.05522673059046762
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000843882	0.05522673059046762
ALAZAMI SYNDROME; ALAZS	0.000843882	0.05522673059046762
LOWRY-MACLEAN SYNDROME	0.000843882	0.05522673059046762
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000843882	0.05522673059046762
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.000843882	0.05522673059046762
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.000843882	0.05522673059046762
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.000843882	0.05522673059046762
MITOCHONDRIAL SHORT-CHAIN ENOYL-CoA HYDRATASE 1 DEFICIENCY; ECHS1D	0.000843882	0.05522673059046762
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000843882	0.05522673059046762
BARDET-BIEDL SYNDROME 13; BBS13	0.000843882	0.05522673059046762
BARDET-BIEDL SYNDROME 8; BBS8	0.000843882	0.05522673059046762
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.000843882	0.05522673059046762
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.000843882	0.05522673059046762
#611936 CHROMOSOME 3q29 DUPLICATION SYNDROME;;MICRODUPLICATION 3q29 SYNDROME	0.000843882	0.05522673059046762
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.000843882	0.05522673059046762
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.000843882	0.05522673059046762
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.000843882	0.05522673059046762
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.000843882	0.05522673059046762
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000843882	0.05522673059046762
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.000843882	0.05522673059046762
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.000843882	0.05522673059046762
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.000843882	0.05522673059046762
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.000843882	0.05522673059046762
HOLOPROSENCEPHALY 3; HPE3	0.000843882	0.05522673059046762
HYPOTONIA-CYSTINURIA SYNDROME	0.000843882	0.05522673059046762
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.000843882	0.05522673059046762
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.000843882	0.05522673059046762
CULLER-JONES SYNDROME; CJS	0.000843882	0.05522673059046762
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.000843882	0.05522673059046762
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000843882	0.05522673059046762
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.000843882	0.05522673059046762
STEEL SYNDROME; STLS	0.000843882	0.05522673059046762
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000843882	0.05522673059046762
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.000843882	0.05522673059046762
#613076 MYOPATHY, MITOCHONDRIAL PROGRESSIVE, WITH CONGENITAL CATARACT, HEARINGLOSS, AND DEVELOPMENTAL DELAY;;MYOPATHY WITH CATARACT AND COMBINED RESPIRATORY CHAIN DEFICIENCY;;MITOCHONDRIAL COMPLEX DEFICIENCY, COMBINED	0.000843882	0.05522673059046762
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000843882	0.05522673059046762
#615401 IMMUNODEFICIENCY 8; IMD8	0.000843882	0.05522673059046762
NEPHRONOPHTHISIS 11; NPHP11	0.000843882	0.05522673059046762
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.000843882	0.05522673059046762
#600638 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULARINVOLVEMENT; CFEOM3A;;FEOM3 LOCUS	0.000843882	0.05522673059046762
JOUBERT SYNDROME 8	0.000843882	0.05522673059046762
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000843882	0.05522673059046762
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.000843882	0.05522673059046762
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.000843882	0.05522673059046762
#614213 NEUROPATHY, HEREDITARY SENSORY, TYPE IIC; HSN2C	0.000843882	0.05522673059046762
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000843882	0.05522673059046762
FORSYTHE-WAKELING SYNDROME; FWS	0.000843882	0.05522673059046762
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.000843882	0.05522673059046762
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.000843882	0.05522673059046762
#610758 CEREBROOCULOFACIOSKELETAL SYNDROME 4; COFS4	0.000843882	0.05522673059046762
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.000843882	0.05522673059046762
OPTIC ATROPHY 11; OPA11	0.000843882	0.05522673059046762
#300895 OHDO SYNDROME, X-LINKED; OHDOX;;BLEPHAROPHIMOSIS-MENTAL RETARDATION SYNDROME, MAAT-KIEVIT-BRUNNERTYPE	0.000843882	0.05522673059046762
JOUBERT SYNDROME 17; JBTS17	0.000843882	0.05522673059046762
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000843882	0.05522673059046762
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.000843882	0.05522673059046762
RAHMAN SYNDROME	0.000843882	0.05522673059046762
CREE MENTAL RETARDATION SYNDROME	0.000843882	0.05522673059046762
#607694 LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/ORHYPOGONADOTROPIC HYPOGONADISM; HLD7;;LEUKOENCEPHALOPATHY, HYPOMYELINATING, WITH ATAXIA AND DELAYED DENTITION;;ATAXIA, DELAYED DENTITION, AND HYPOMYELINATION; ADDH;;LEUKODYSTROPHY, HYPOMYELINATING, WITH HYPODONTIA AND HYPOGONADOTROPICHYPOGONADISM;;4H SYNDROME	0.000843882	0.05522673059046762
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000843882	0.05522673059046762
SAUL-WILSON SYNDROME; SWILS	0.000843882	0.05522673059046762
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000843882	0.05522673059046762
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.000843882	0.05522673059046762
DYSTONIA 28, CHILDHOOD-ONSET	0.000843882	0.05522673059046762
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.000843882	0.05522673059046762
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.000843882	0.05522673059046762
SILVER-RUSSELL SYNDROME; SRS	0.000843882	0.05522673059046762
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.000843882	0.05522673059046762
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.000843882	0.05522673059046762
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.000843882	0.05522673059046762
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.000843882	0.05522673059046762
AICARDI-GOUTIERES SYNDROME 5	0.000843882	0.05522673059046762
#615220 OSTEOGENESIS IMPERFECTA, TYPE XV; OI15;;OI, TYPE XV	0.000843882	0.05522673059046762
FRIAS SYNDROME	0.000843882	0.05522673059046762
#231550 ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME; AAAS;;TRIPLE-A SYNDROME;;ALACRIMA-ACHALASIA-ADRENAL INSUFFICIENCY NEUROLOGIC DISORDER;;GLUCOCORTICOID DEFICIENCY AND ACHALASIA;;ALLGROVE SYNDROME;;ADDISONIAN-ACHALASIA SYNDROME;;HYPOADRENALISM WITH ACHALASIA;;ALACRIMA-ACHALASIA-ADDISONIANISM;;ACTH-RESISTANT ADRENAL INSUFFICIENCY, ACHALASIA AND ALACRIMAACHALASIA-ALACRIMA SYNDROME, INCLUDED	0.000843882	0.05522673059046762
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.000843882	0.05522673059046762
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.000843882	0.05522673059046762
#300123 MENTAL RETARDATION, X-LINKED, WITH PANHYPOPITUITARISMMENTAL RETARDATION, X-LINKED, WITH ISOLATED GROWTH HORMONE DEFICIENCY,INCLUDED; MRGH, INCLUDED	0.000843882	0.05522673059046762
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000843882	0.05522673059046762
Aarskog-Scott syndrome	0.000843882	0.05522673059046762
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000843882	0.05522673059046762
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.000843882	0.05522673059046762
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000843882	0.05522673059046762
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000843882	0.05522673059046762
#275900 SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE; SPG20;;TROYER SYNDROME;;SPASTIC PARAPARESIS, CHILDHOOD-ONSET, WITH DISTAL MUSCLE WASTING;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, TROYER TYPE	0.000843882	0.05522673059046762
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.000843882	0.05522673059046762
OCULOSKELETODENTAL SYNDROME; OCSKD	0.000843882	0.05522673059046762
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000843882	0.05522673059046762
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.000843882	0.05522673059046762
#615583 VERHEIJ SYNDROME; VRJS;;CHROMOSOME 8q24.3 DELETION SYNDROME	0.000843882	0.05522673059046762
RETINITIS PIGMENTOSA 80; RP80	0.000843882	0.05522673059046762
JOUBERT SYNDROME 28	0.000843882	0.05522673059046762
CHROMOSOME 4q21 DELETION SYNDROME	0.000843882	0.05522673059046762
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.000843882	0.05522673059046762
#614732 INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIACONGENITA, AND GENITAL ANOMALIES;;IMAGE SYNDROME	0.000843882	0.05522673059046762
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.000843882	0.05522673059046762
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000843882	0.05522673059046762
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.000843882	0.05522673059046762
MARINESCO-SJOGREN SYNDROME; MSS	0.000843882	0.05522673059046762
IMMUNODEFICIENCY 23; IMD23	0.000843882	0.05522673059046762
YOU-HOOVER-FONG SYNDROME; YHFS	0.000843882	0.05522673059046762
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.000843882	0.05522673059046762
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000843882	0.05522673059046762
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000843882	0.05522673059046762
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000843882	0.05522673059046762
JOUBERT SYNDROME 15	0.000843882	0.05522673059046762
MACROCEPHALY/AUTISM SYNDROME	0.000843882	0.05522673059046762
CHROMOSOME 15q25 DELETION SYNDROME	0.000843882	0.05522673059046762
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000843882	0.05522673059046762
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.000843882	0.05522673059046762
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.000843882	0.05522673059046762
#609054 FANCONI ANEMIA, COMPLEMENTATION GROUP J; FANCJ	0.000843882	0.05522673059046762
JOUBERT SYNDROME 10	0.000843882	0.05522673059046762
LARSEN-LIKE SYNDROME	0.000843882	0.05522673059046762
BARDET-BIEDL SYNDROME 1; BBS1	0.000843882	0.05522673059046762
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000843882	0.05522673059046762
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.000843882	0.05522673059046762
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.000843882	0.05522673059046762
PEROXISOME BIOGENESIS DISORDER 3B	0.000843882	0.05522673059046762
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.000843882	0.05522673059046762
DIAPHANOSPONDYLODYSOSTOSIS	0.000843882	0.05522673059046762
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000843882	0.05522673059046762
SWEENEY-COX SYNDROME; SWCOS	0.000843882	0.05522673059046762
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000843882	0.05522673059046762
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000843882	0.05522673059046762
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.000843882	0.05522673059046762
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.000843882	0.05522673059046762
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.000843882	0.05522673059046762
#612626 CHROMOSOME 15q26-qter DELETION SYNDROME;;DRAYER SYNDROME	0.000843882	0.05522673059046762
Jawad syndrome	0.000843882	0.05522673059046762
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.000843882	0.05522673059046762
#615665 JOUBERT SYNDROME 22; JBTS22	0.000843882	0.05522673059046762
SENIOR-LOKEN SYNDROME 9	0.000843882	0.05522673059046762
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.000843882	0.05522673059046762
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.000843882	0.05522673059046762
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.000843882	0.05522673059046762
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.000843882	0.05522673059046762
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.000843882	0.05522673059046762
RICHARDS-RUNDLE SYNDROME; RRNS	0.000843882	0.05522673059046762
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ig; CDG1G	0.000843882	0.05522673059046762
JOUBERT SYNDROME 31; JBTS31	0.000843882	0.05522673059046762
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.000843882	0.05522673059046762
CHROMOSOME 18P DELETION SYNDROME	0.000843882	0.05522673059046762
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.000843882	0.05522673059046762
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.000843882	0.05522673059046762
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000843882	0.05522673059046762
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.000843882	0.05522673059046762
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.000843882	0.05522673059046762
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.000843882	0.05522673059046762
CRANIOSYNOSTOSIS 6; CRS6	0.000843882	0.05522673059046762
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.000843882	0.05522673059046762
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.000843882	0.05522673059046762
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.000843882	0.05522673059046762
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000843882	0.05522673059046762
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000843882	0.05522673059046762
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.000843882	0.05522673059046762
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.000843882	0.05522673059046762
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000843882	0.05522673059046762
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.000843882	0.05522673059046762
CHROMOSOME Xq27.3-q28 DUPLICATION SYNDROME	0.000843882	0.05522673059046762
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.000843882	0.05522673059046762
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000843882	0.05522673059046762
ALSTROM SYNDROME; ALMS	0.000843882	0.05522673059046762
#170100 PROLIDASE DEFICIENCY	0.000843882	0.05522673059046762
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.000843882	0.05522673059046762
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.000843882	0.05522673059046762
HYDROXYKYNURENINURIA	0.000843882	0.05522673059046762
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.000843882	0.05522673059046762
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.000843882	0.05522673059046762
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.000843882	0.05522673059046762
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.000843882	0.05522673059046762
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000843882	0.05522673059046762
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.000843882	0.05522673059046762
PELLAGRA-LIKE SYNDROME	0.000843882	0.05522673059046762
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.000843882	0.05522673059046762
AUSTRALIA ANTIGEN	0.000843882	0.05522673059046762
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.000843882	0.05522673059046762
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.000843882	0.05522673059046762
#607454 SPINOCEREBELLAR ATAXIA 21; SCA21	0.000843882	0.05522673059046762
#609425 CHROMOSOME 3q29 DELETION SYNDROME;;MICRODELETION 3q29 SYNDROME	0.000843882	0.05522673059046762
JOUBERT SYNDROME 32; JBTS32	0.000843882	0.05522673059046762
CRANIOTELENCEPHALIC DYSPLASIA	0.000843882	0.05522673059046762
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000843882	0.05522673059046762
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.000843882	0.05522673059046762
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.000843882	0.05522673059046762
MEVALONIC ACIDURIA; MEVA	0.000843882	0.05522673059046762
THAUVIN-ROBINET-FAIVRE SYNDROME	0.000843882	0.05522673059046762
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.000843882	0.05522673059046762
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000843882	0.05522673059046762
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.000843882	0.05522673059046762
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.000843882	0.05522673059046762
#608443 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 3; MRT3	0.000843882	0.05522673059046762
#610185 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME2; CAMRQ2;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDALLOCOMOTION 2	0.000843882	0.05522673059046762
#610915 OSTEOGENESIS IMPERFECTA, TYPE VIII; OI8;;OI, TYPE VIII	0.000843882	0.05522673059046762
HARTSFIELD SYNDROME; HRTFDS	0.000843882	0.05522673059046762
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.000843882	0.05522673059046762
NAVAJO NEUROHEPATOPATHY	0.000843882	0.05522673059046762
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.000843882	0.05522673059046762
TARP SYNDROME; TARPS	0.000843882	0.05522673059046762
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.000843882	0.05522673059046762
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.000843882	0.05522673059046762
BARDET-BIEDL SYNDROME 16; BBS16	0.000843882	0.05522673059046762
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000843882	0.05522673059046762
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.000843882	0.05522673059046762
#609528 CEREBRAL DYSGENESIS, NEUROPATHY, ICHTHYOSIS, AND PALMOPLANTAR KERATODERMASYNDROME;;CEDNIK SYNDROME	0.000843882	0.05522673059046762
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000843882	0.05522673059046762
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.000843882	0.05522673059046762
GALACTOSE EPIMERASE DEFICIENCY	0.000843882	0.05522673059046762
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.000843882	0.05522673059046762
NOONAN SYNDROME 2; NS2	0.000843882	0.05522673059046762
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.000843882	0.05522673059046762
#614582 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 9; COXPD9	0.000843882	0.05522673059046762
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.000843882	0.05522673059046762
JOUBERT SYNDROME 26	0.000843882	0.05522673059046762
#614728 SECKEL SYNDROME 6; SCKL6	0.000843882	0.05522673059046762
PEROXISOME BIOGENESIS DISORDER 10B	0.000843882	0.05522673059046762
JOUBERT SYNDROME 25	0.000843882	0.05522673059046762
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000843882	0.05522673059046762
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000843882	0.05522673059046762
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000843882	0.05522673059046762
#613641 CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE B; CMTRIB;;CHARCOT-MARIE-TOOTH NEUROPATHY, RECESSIVE INTERMEDIATE B; RI-CMTB	0.000843882	0.05522673059046762
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.000843882	0.05522673059046762
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.000843882	0.05522673059046762
CURRY-JONES SYNDROME	0.000843882	0.05522673059046762
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.000843882	0.05522673059046762
METHYLMALONIC ACIDURIA, CBLB TYPE	0.000843882	0.05522673059046762
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.000843882	0.05522673059046762
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000843882	0.05522673059046762
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.000843882	0.05522673059046762
AICARDI-GOUTIERES SYNDROME 6	0.000843882	0.05522673059046762
#615432 SPECIFIC LANGUAGE IMPAIRMENT 5; SLI5	0.000843882	0.05522673059046762
SPINOCEREBELLAR ATAXIA 5; SCA5	0.000843882	0.05522673059046762
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000843882	0.05522673059046762
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.000843882	0.05522673059046762
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000843882	0.05522673059046762
TONNE-KALSCHEUER SYNDROME; TOKAS	0.000843882	0.05522673059046762
OROFACIODIGITAL SYNDROME VI	0.000843882	0.05522673059046762
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000843882	0.05522673059046762
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.000843882	0.05522673059046762
#615066 OSTEOGENESIS IMPERFECTA, TYPE XIV; OI14 ;;OI, TYPE XIV	0.000843882	0.05522673059046762
LAMB-SHAFFER SYNDROME	0.000843882	0.05522673059046762
BARDET-BIEDL SYNDROME 3; BBS3	0.000843882	0.05522673059046762
AL-RAQAD SYNDROME; ARS	0.000843882	0.05522673059046762
JOUBERT SYNDROME 33; JBTS33	0.000843882	0.05522673059046762
DIAMOND-BLACKFAN ANEMIA 5	0.000843882	0.05522673059046762
JOUBERT SYNDROME 6	0.000843882	0.05522673059046762
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.000843882	0.05522673059046762
MICROPHTHALMIA, SYNDROMIC 3	0.000843882	0.05522673059046762
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000843882	0.05522673059046762
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000843882	0.05522673059046762
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.000843882	0.05522673059046762
ADAMS-OLIVER SYNDROME 3; AOS3	0.000843882	0.05522673059046762
BARDET-BIEDL SYNDROME 17; BBS17	0.000843882	0.05522673059046762
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.000843882	0.05522673059046762
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000843882	0.05522673059046762
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.000843882	0.05522673059046762
OROFACIODIGITAL SYNDROME IX; OFD9	0.000843882	0.05522673059046762
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000843882	0.05522673059046762
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.000843882	0.05522673059046762
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.000843882	0.05522673059046762
JOUBERT SYNDROME 23; JBTS23	0.000843882	0.05522673059046762
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.000843882	0.05522673059046762
ROIFMAN SYNDROME; RFMN	0.000843882	0.05522673059046762
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000843882	0.05522673059046762
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000843882	0.05522673059046762
REVESZ SYNDROME	0.000843882	0.05522673059046762
WARSAW BREAKAGE SYNDROME; WABS	0.000843882	0.05522673059046762
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.000843882	0.05522673059046762
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.000843882	0.05522673059046762
ARIMA SYNDROME	0.000843882	0.05522673059046762
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.000843882	0.05522673059046762
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.000843882	0.05522673059046762
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.000843882	0.05522673059046762
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.000843882	0.05522673059046762
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.000843882	0.05522673059046762
Leukotriene C4 synthase deficiency	0.000843882	0.05522673059046762
#615314 CRANIOSYNOSTOSIS 3; CRS3	0.000843882	0.05522673059046762
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000843882	0.05522673059046762
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000843882	0.05522673059046762
#303110 CHOROIDEREMIA, DEAFNESS, AND MENTAL RETARDATION;;CHROMOSOME Xq21 DELETION SYNDROME	0.000843882	0.05522673059046762
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000843882	0.05522673059046762
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.000843882	0.05522673059046762
MECKEL SYNDROME 13; MKS13	0.000843882	0.05522673059046762
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.000843882	0.05522673059046762
OROFACIODIGITAL SYNDROME XVI; OFD16	0.000843882	0.05522673059046762
JOUBERT SYNDROME 7	0.000843882	0.05522673059046762
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.000843882	0.05522673059046762
#612714 EXOCRINE PANCREATIC INSUFFICIENCY, DYSERYTHROPOIETIC ANEMIA, AND CALVARIALHYPEROSTOSIS	0.000843882	0.05522673059046762
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000843882	0.05522673059046762
MENTAL RETARDATION, X-LINKED 106; MRX106	0.000843882	0.05522673059046762
#614970 JOUBERT SYNDROME 20; JBTS20	0.000843882	0.05522673059046762
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.000843882	0.05522673059046762
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.000843882	0.05522673059046762
#267000 PERLMAN SYNDROME; PRLMNS;;RENAL HAMARTOMAS, NEPHROBLASTOMATOSIS, AND FETAL GIGANTISM;;NEPHROBLASTOMATOSIS, FETAL ASCITES, MACROSOMIA, AND WILMS TUMOR	0.000843882	0.05522673059046762
#613752 HYPERMETHIONINEMIA WITH S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.000843882	0.05522673059046762
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000843882	0.05522673059046762
#227810 FANCONI-BICKEL SYNDROME; FBS;;HEPATORENAL GLYCOGENOSIS WITH RENAL FANCONI SYNDROME;;HEPATIC GLYCOGENOSIS WITH FANCONI NEPHROPATHY;;HEPATIC GLYCOGENOSIS WITH AMINO ACIDURIA AND GLUCOSURIA;;FANCONI SYNDROME WITH INTESTINAL MALABSORPTION AND GALACTOSE INTOLERANCE;;PSEUDO-PHLORIZIN DIABETES;;GLYCOGENOSIS, FANCONI TYPE;;GLYCOGEN STORAGE DISEASE XI	0.000843882	0.05522673059046762
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.000843882	0.05522673059046762
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.000843882	0.05522673059046762
SECKEL SYNDROME 8; SCKL8	0.000843882	0.05522673059046762
JOUBERT SYNDROME 21	0.000843882	0.05522673059046762
